

















Biofilms are structured communities of bacteria that adhere to surfaces and shield 
bacteria from hostile surroundings. They are implicated in 75% of all infections in 
humans and are difficult to treat. New therapies are being developed to combat 
biofilm infections, such as quorum sensing inhibition (quorum quenching). 
Quorum sensing is a process where bacteria use chemical signals to communicate 
with individuals in a group for co-operative processes such as biofilm formation. I 
investigated how quorum quenching can be carried out using enzymes to degrade 
quorum-sensing signals, particularly acyl-homoserine lactones (AHLs) used by 
Gram-negative bacteria. AHL acylases are enzymes known to be involved in 
quorum quenching. However, they are expressed poorly in native and heterologous 
hosts and difficult to purify for further study, limiting their use. Therefore, I chose a 
related acylase as a scaffold to engineer AHL acylase activity using structure-based 
mutagenesis. As this scaffold did not have prior activity against AHLs, I developed 
a sensitive high-throughput screen to detect engineered AHL acylase variants. 
From 637 variants screened, this is the first time a variant of this scaffold was 
found to be active against AHLs. This engineered AHL acylase is active against 3-
oxododecanoyl homoserine lactone (3-oxo-C12-HSL), the quorum-sensing signal 
of the clinical pathogen Pseudomonas aeruginosa PAO1. When tested against P. 
aeruginosa biofilms, the acylase reduced the extracellular matrix surrounding the 
cells, indicating potential for further clinical application. The position mutated in 
this engineered AHL acylase was found to be critical not only for substrate 
specificity but also for autocatalytic processing, providing new insight for this 
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PsGK16 Pseudomonas sp. GK16 (Ichikawa et al., 1981a) 
PvdQ  P. aeruginosa PAO1 AHL acylase from the gene PA2385 
involved in pyoverdin synthesis (Lamont and Martin, 2003) 
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Biofilm infections can occur in situations where the human body is compromised 
over a long period, such as with chronic wounds, implantation of medical devices 
and diseases such as cystic fibrosis (Donlan and Costerton, 2002). About 75% of all 
infections in humans are due to the presence of biofilms (Richards and Melander, 
2009). Once microorganisms foreign to the human body are established as a 
biofilm, such infections can cause patients to be sick longer. This leads to further 
health complications and financial burden (Percival et al., 2015). 
Bacteria exist as biofilms in nature as opposed to the single-celled, planktonic state 
researchers are familiar with in the laboratory (Flemming and Wingender, 2010). 
Bacterial biofilms can occur on liquid and solid surfaces including bodies of water, 
rocks, industrial equipment and in organisms. 
Bacterial biofilms are communities surrounded by a matrix that sticks the bacteria 
to surfaces (Flemming et al., 2016). A biofilm is predominantly made up of the 
matrix with a small proportion of inhabiting bacteria (Flemming and Wingender, 
2010). The matrix is made up of substances like polysaccharides, DNA, proteins 
and lipids, which help to protect the bacteria encased in it. 
Several microorganisms that produce biofilms are a major cause of infections in 
humans, including Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli) 
and Staphylococcus aureus (Donlan and Costerton, 2002). These bacteria produce 
biofilms when they infect humans and can resist treatment from antimicrobial 
agents. 
1.1.2 Biofilm	persistence	and	adaptability	
The persistence and adaptability of biofilms allows them to survive in many 
environments and chronically infect the human body as well (Hall and Mah, 2017). 
It is known that biofilms are far more tolerant to antimicrobial agents than bacteria 
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in a planktonic state (Stewart and Costerton, 2001). There are several reasons for 
this (Figure 1.1), but it is important to acknowledge that these are very much 
dependent on the context. 
 
Figure 1.1 Factors in a biofilm that contribute to resistance to antimicrobial 
agents. Adapted from Stewart and Costerton (2001) and Flemming et al. (2016). 
For example, different parts of the biofilm are exposed to varying amounts of 
oxygen and nutrients (Stewart and Franklin, 2008). Bacteria inhabiting areas with 
less oxygen and nutrients will have slower growth and metabolism. In this state, 
antimicrobial agents that inhibit growth, such as antibiotics, may not have an 
effect. Different species of inhabiting bacteria will also have different responses to 
their immediate environments. Bacteria can use efflux pumps to expel 
antimicrobial agents from their intracellular environment (Masuda et al., 2000). 
Extracellular components in the matrix of a biofilm such as extracellular DNA 
(eDNA) (Chiang et al., 2013) and enzymes (Bagge et al., 2004) can also bind or 
degrade antimicrobial agents.  
Since several mechanisms contribute to antimicrobial resistance in biofilms (Figure 
1.1), there should be several therapies to try and combat biofilm infections. These 
have been reviewed extensively (Beloin et al., 2014; Taylor et al., 2014; Ruer et al., 
2015). It is known that bacteria coordinate with each other using quorum sensing 
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for biofilm formation (O'Toole et al., 2000). Thus, quorum sensing can be targeted 
to disrupt biofilms. 
1.2 Quorum	sensing	
Quorum sensing refers to the chemical communication systems bacteria use to 
monitor population density and mediate specific coordinated behaviours under 
given circumstances (Fuqua et al., 1994). A small population of bacteria initially 
produces a low basal concentration of the chemical signal. As the population 
grows, so does the signal concentration. When it reaches a specific threshold, 
indicating a critical population density, changes in transcription will occur in the 
population, affecting regulation of many processes (Miller and Bassler, 2001). This 
includes bioluminescence, virulence, biofilm formation, pigmentation, motility, 
competence for DNA uptake and sporulation (Diggle et al., 2007). Quorum sensing 
regulates these processes when a sufficiently large population is present because 
they benefit the group as opposed to a single individual (Waters and Bassler, 2005).  
Quorum sensing requires synthesis, transport, reception and transduction of the 
signal (Figure 1.2). 
 
Figure 1.2 Quorum sensing. 
1.2.1 Quorum-sensing	signals	
A wide range of quorum sensing signals is known (Hawver et al., 2016) (Figure 
1.3). Acyl-homoserine lactones (AHLs) and peptide signals are the best 
characterised. Each is thought to be exclusive to Gram-negative and Gram-positive 
bacteria, respectively. Other signals share structures in common with AHLs. While 
the signals may be different, production, transport, reception and transduction 
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proceed in similar ways. Some have also been shown to allow different species to 
communicate (Bassler et al., 1997; Schauder et al., 2001). 
 
Figure 1.3 Quorum-sensing signals. (A) Examples of AHLs, (B) examples of 
linear and cyclic peptides, (C) AHL-like signals and (D) tetrahydroxytetrafurans. 
This project aims to inhibit AHL-based quorum sensing to block biofilm formation 
by P. aeruginosa PAO1. The following sections give a brief overview of AHL-based 
quorum sensing and its role in relation to P. aeruginosa PAO1 biofilm formation in 
more detail. 
1.2.2 AHL-based	quorum	sensing		
First identified in the bioluminescent Vibrio fischeri (Eberhard et al., 1981), AHL-
based quorum sensing has been confirmed in many Gram-negative bacteria 
(Hawver et al., 2016; Papenfort and Bassler, 2016).  
AHLs are composed of a homoserine lactone (HSL) ring attached to an acyl chain 
through an amide bond (Figure 1.3A). The HSL ring is a common unit among all 
AHLs. The acyl chain can be four to fourteen carbon atoms in length and may 
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have a modified side group on the third carbon, which can be a methylene, 
hydroxyl or oxo-group (Dickschat, 2010).  
AHL synthases make these signals in the cell (Val and Cronan, 1998). The AHLs 
are then transported to reach other cells. Shorter chain AHLs are thought to diffuse 
through the cell membrane while longer ones pass through efflux pumps to avoid 
getting stuck in the lipid bilayer (Pearson et al., 1999). When AHLs enter a cell, 
receptors bind them and then bind DNA to modulate gene transcription for the 
necessary responses (Whitehead et al., 2001). The established nomenclature for 
AHL-based quorum sensing refers to the synthase/receptor combination, e.g. the 
Vibrio fischeri LuxI/R system. 
1.2.3 The	role	of	AHL-based	quorum	sensing	in	biofilm	formation	
AHL-based quorum sensing contributes to biofilm formation in Gram-negative 
bacteria. Davies et al. (1998) first demonstrated this in P. aeruginosa PAO1. The 
LasI/R system uses 3-oxododecanoyl homoserine lactone (3-oxo-C12-HSL) 
(Pearson et al., 1994) while the RhlI/R system uses butanoyl homoserine lactone 
(C4-HSL) (Pearson et al., 1995) in P. aeruginosa PAO1. The RhlI/R system is also 
positively regulated by the LasI/R system when LasR is activated (Lee and Zhang, 
2015). Davies et al. (1998) showed that the lasI-rhlI double mutant produces 
biofilms that do not have the complex architecture of the wild-type strain. The rhlI 
mutant produces biofilms more like the wild type, while the lasI mutant produce 
biofilms more like the lasI-rhlI double mutant, showing that the LasI/R system has 
a stronger influence on biofilm formation. Exposure to SDS caused dispersion of 
the lasI mutant biofilm compared to the wild type, due to the change in the 
structure of the biofilm caused by the mutation. 
In Burkholderia cepacia, cepI and cepR mutants formed biofilms that also had 
different structures compared to the wild type (Huber et al., 2001). Both mutants 
showed low biofilm mass when grown in microplates and did not develop past the 
microcolony stage when grown in flow chambers. The swrI mutant of Serratia 
liquefaciens also does not form the complex biofilm structure as observed with the 
wild type (Labbate et al., 2004). Two strains with mutations in genes known to be 
regulated by quorum sensing had impaired biofilm formation same as the swrI 
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mutant when grown in flow chambers. In Aeromonas hydrophila, the ahyI mutant 
could not produce the complex biofilm structure compared to the wild type but the 
ahyR mutant produced a biofilm structure similar to that of the wild type but with a 
larger surface area (Lynch et al., 2002).  
Based on the differences in biofilm structures produced by different quorum-
sensing mutants, it is clear that quorum sensing affects biofilm formation (Irie and 
Parsek, 2008). Therefore, new therapies can be developed based on inhibition of 
quorum sensing to combat biofilm formation. 
1.3 Quorum	quenching	
Quorum sensing inhibition, also known as quorum quenching, is a potentially 
useful form of antimicrobial activity (Dong et al., 2007). Typically, bacterial 
infections in humans are treated with antibiotics, which kill bacteria or inhibit their 
growth (Costerton et al., 1999). Selection pressure to develop resistance in these 
cases is high. Quorum sensing affects processes like production of virulence factors 
and biofilm formation that allow bacteria to infect humans. Quorum quenching is 
hypothesised to inhibit these processes that contribute to infections in humans 
without killing bacteria (Finch et al., 1998). This suggests that there would be low 
selection pressure for bacteria to develop resistance to quorum quenchers (Cegelski 
et al., 2008; Uroz et al., 2009).  
Quorum sensing requires signal production, transport and reception (Figure 1.2) 
and therefore can be inhibited with molecules that inhibit these processes, or with 
enzymes that degrade the signals themselves (Figure 1.4). Quorum quenchers have 
been reviewed extensively (LaSarre and Federle, 2013; Fetzner, 2015; 
Grandclément et al., 2015). 
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Figure 1.4 Methods of quorum quenching. (A) Small-molecule inhibition of 
signal production. (B) Enzymatic signal degradation. (C) Small-molecule 
inhibition of signal reception. (D) Small-molecule inhibition of signal 
transduction. 
1.3.1 Quorum	quenching	for	AHLs:	Blocking	signal	production	and	reception	
Small molecules can act as quorum quenchers by blocking production or reception 
of AHLs (Kalia, 2013). The focus has largely been on inhibiting AHL reception 
and few groups have worked on inhibiting AHL synthesis (Galloway et al., 2012). 
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Figure 1.5 Quorum-quenchers that block signal production or reception. (A) 
Adenosyl cysteine. (B) Trans-cinnamaldehyde (Chang et al., 2014). (C) J8-C8 
(Chung et al., 2011). (D) C-30 furanone (Manefield et al., 2002). (E) 3-oxo-C12-2-
aminocyclohexanone (Smith et al., 2003). (F) Bromophenyl AHL (Geske et al., 
2005). (G) Meta-bromo-thiolactone (O’Loughlin et al., 2013). (H) Compound 3 
(Riedel et al., 2006). (I) N-nonanoyl-cyclopentylamide (Morohoshi et al., 2007). 
Both substrate and product analogues can be used to inhibit AHL synthesis. 
Adenosyl cysteine (Figure 1.5A) inhibits the P. aeruginosa PAO1 RhlI, which 
makes C4-HSL (Parsek et al., 1999). It is an analogue of S-adenosylmethionine, a 
common core substrate for AHL synthesis. Further work has yet to be done on 
these inhibitors for quorum quenching but this study highlights their potential. 
Trans-cinnamaldehyde (Figure 1.5B) also inhibits RhlI (Chang et al., 2014). This 
was shown by detection with RhlI-expressing E. coli and reduced P. aeruginosa 
PAO1 pyocyanin production, which is regulated by Rhl quorum sensing. J8-C8 
(Figure 1.5C), an octanoyl-homoserine lactone (C8-HSL) analogue binds to the 
Burkholderia glumae TofI synthase and reduces synthesis of C8-HSL (Chung et al., 
2011). The TofI synthase is the only inhibitor-bound AHL synthase structure 
known.  
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Most quorum quenchers have been developed to inhibit AHL receptors, 
particularly LasR of P. aeruginosa PAO1. The synthetic furanone C-30 derived from 
Delisea pulchra (Figure 1.5D) was thought to inhibit quorum sensing by binding to 
LasR, causing it to destabilise and degrade (Manefield et al., 2002). P. aeruginosa 
PAO1 biofilms grown with this molecule were dissolved by overnight treatment 
with SDS compared to non-treated biofilms (Hentzer et al., 2003). When treated 
with the antibiotic tobramycin, 90% of cells in C-30-treated biofilms were killed 
whereas only cells at the surface of the non-treated biofilm were killed (Hentzer et 
al., 2003). Other quorum quenchers include 3-oxo-C12-2-aminocyclohexanone 
(Smith et al., 2003), bromophenyl-AHL (Geske et al., 2005) and meta-bromo-
thiolactone (O’Loughlin et al., 2013) (Figure 1.5E-G). The first two prevent 
binding to LasR and the third prevents RhlR binding. All three inhibit biofilm 
formation. 
Quorum quenching and biofilm inhibition has also been demonstrated in other 
species. A rationally designed chemical (Figure 1.5H) reduced the biofilm mass of 
wild-type Burkholderia cenocepacia H111 to that of the mutant that cannot produce 
the C8-HSL signal (Riedel et al., 2006). The quorum-quencher N-nonanoyl-
cyclopentylamide (Figure 1.5I) was shown to reduce biofilm mass of Serratia 
marcescens AS-1 in a competition assay using a mutant that could not produce 
hexanoyl-homoserine lactone (C6-HSL), one of the strain’s quorum-sensing signals 
(Morohoshi et al., 2007). 
Many options are available to develop small-molecule quorum quenchers. 
However, both mechanisms of action and the effect on processes downstream of 
quorum sensing must be demonstrated. Apart from inhibiting signal production 
and reception, quorum quenching can also be carried out by signal degradation. 
1.3.2 Quorum	quenching	for	AHLs:	Signal	degradation	
Enzymes that degrade quorum-sensing signals can be used for quorum quenching 
(Fetzner, 2015; Grandclément et al., 2015). In contrast to small molecule quorum 
quenchers, enzymes can function outside of the cell as quorum-sensing signals 
need to travel through extracellular environments.  
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Currently known microbial quorum-quenching enzymes that degrade AHLs are 
divided into lactonases and acylases. Lactonases break open the HSL ring, 
producing acyl-homoserine while acylases break the amide bond, producing a fatty 
acid and HSL (Figure 1.6). The HSL ring broken by the lactonase can be reformed 
(Yates et al., 2002) while the amide bond is irreversibly broken by the acylase 
because the fatty acid can be metabolised (Leadbetter and Greenberg, 2000). 
Therefore, acylases may be the better option for quorum quenching. 
 
Figure 1.6 AHL degradation. (A) Lactonases. (B) Acylases. 
1.3.2.1 AHL	lactonases	
The first AHL lactonase AiiA was discovered in Bacillus sp. 240B1 (Dong et al., 
2000; Wang et al., 2004). Others include the Agrobacterium tumefaciens AiiB (Liu et 
al., 2007), Thermaerobacter marianensis AiiT (Morohoshi et al., 2014), Muricauda 
olearia MomL (Tang et al., 2015) and Planococcus versutus AidP (See-Too et al., 
2017). These have structures similar to zinc metallo-β-lactamases (Kim et al., 2005) 
(Figure 1.7). Two lactonases, AidH (Gao et al., 2013) and AiiM (Migiyama et al., 
2013) are thought to be from the alpha/beta hydrolase family. 
There are also TIM barrel AHL lactonases (Afriat et al., 2006) (Figure 1.7). Many 
are derived from thermophiles and all have promiscuous activities (Hiblot et al., 
2012; Kallnik et al., 2014; Koch et al., 2014a). TIM barrel AHL lactonases have 
been the focus of engineering to broaden AHL substrate specificity (Chow et al., 
2009; Chow et al., 2010; Hiblot et al., 2013). Variants had mutations in the loops at 
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Figure 1.7 AHL lactonases. (A) Zinc metallo-β-lactamase-like AHL lactonase, 
Bacillus thuringiensis AiiA (PDB ID 2BTN). (B) TIM barrel AHL lactonase, 
Geobacillus kaustophilus GKL (PDB ID 3OJG). Alpha helices in blue, beta 
sheets in cyan and loop regions in grey. 
The Sulfolobus solfataricus lactonase was able to reduce protease and pyocyanin 
synthesis in P. aeruginosa PAO1 cultures after immobilisation on nanoalumina 
membranes (Ng et al., 2011). An engineered variant of this lactonase could also 
reduce protease and pyocyanin synthesis in P. aeruginosa PAO1 cultures after 
immobilisation on polyurethane coating (Guendouze et al., 2017). This shows that 
enzymes can be immobilised on solid supports to develop therapeutics for quorum 
quenching. 
1.3.2.2 AHL	acylases	
Microbial AHL acylase activity was first discovered in Variovorax paradoxus VAI-C 
(Leadbetter and Greenberg, 2000). Although a protein was not identified, the 
bacteria could grow on AHLs and produce HSL. The Ralstonia XJ12B AiiD was 
the first characterised AHL acylase (Lin et al., 2003). Purified AiiD could cleave 3-
oxo-decanoyl homoserine lactone, forming the HSL and fatty acid products. 
Other AHL acylases have been discovered and characterised since then. The best-
studied ones are derived from the Pseudomonads (Krzeslak et al., 2007). The solved 
structure of the P. aeruginosa PAO1 PvdQ indicated that AHL acylases as 
members of the N-terminal nucleophile hydrolase family (Bokhove et al., 2010) 
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(Figure 1.8). Proteins of this family vary widely in their substrate specificities and 
sequence identities (Brannigan et al., 1995; Oinonen and Rouvinen, 2000). N-
terminal nucleophile hydrolases are expressed as a single polypeptide with a signal 
sequence, a small α subunit, a spacer and a larger β subunit from N- to C-
terminal, respectively. The signal sequence directs the polypeptide to where it is 
required to be folded (Randall and Hardy, 1989). Once the signal sequence is 
removed, the folded enzyme then catalyses the removal of its own spacer to form 
the active enzyme (Brannigan et al., 1995). Therefore, these enzymes can only 
catalyse substrate degradation if they are processed correctly. This autocatalytic 
removal of the spacer is further described in Section 1.4. The functional enzyme 
then has the first N-terminal residue of the β subunit exposed, which is involved in 











Figure 1.8 Structures of AHL acylases. (A) P. aeruginosa PAO1 PvdQ (PBD 
2WYC). (B) Catalytic residues of PvdQ. (C) Acidovorax sp. strain MR-S7 MacQ 
(PDB 4YFA). (D) Catalytic residues of MacQ. α subunits shown in cyan and 
green, β subunits shown in blue and forest for PvdQ and MacQ, respectively. 
Catalytic residues shown as sticks, carbon atoms in grey, nitrogen atoms in 
blue and oxygen atoms in red. Residues numbered by full-length sequence. 
PvdQ functions in pyoverdin synthesis (Lamont and Martin, 2003). However, it 
was also identified as a Ralstonia AiiD homologue and degrades 3-oxo-C12-HSL, 
the P. aeruginosa PAO1 Las quorum-sensing signal (Huang et al., 2003). Expression 
of PvdQ in E. coli produced mostly unprocessed protein. However, enough active 
PvdQ was present to degrade 3-oxo-C12-HSL. Sio et al. (2006) also independently 
identified PvdQ as a homologue of the Pseudomonas sp. GK16 (PsGK16) glutaryl-7-
aminocephalosporanic acid (GL7-ACA) acylase and showed that PvdQ had AHL 
acylase activity. Active PvdQ has a small α subunit (residues 24-194) and a large β 
subunit (residues 217-762). The full-length, unprocessed PvdQ includes a signal 
sequence (residues 1-23) and spacer peptide (residues 195-216). PvdQ has been 
shown to reduce 3-oxo-C12-HSL production when over-expressed in or externally 
administered to P. aeruginosa PAO1 and delays killing of Pseudomonas-infected 
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nematodes (Papaioannou et al., 2009). PvdQ has also been formulated into a 
powder for potential treatment of cystic fibrosis (Wahjudi et al., 2013). 
PvdQ contains a typical N-terminal nucleophile hydrolase active site (Bokhove et 
al., 2010) (Figure 1.8). Ser217 provides the nucleophilic hydroxyl group to attack 
the carbonyl carbon of the AHL and hydrolyse the amide bond. His239 positions 
Ser217 to carry out this nucleophilic attack. Val286 and Asn485 help to position 
the AHL for hydrolysis. Arg513 positions Asn485 to carry out this role. The 
substrate-binding pocket of PvdQ is extensive and composed of hydrophobic 
residues to accommodate the 3-oxo-C12-HSL acyl chain. Phe240 controls solvent 
exposure of the pocket and opens so the substrate can bind. PvdQ has six cysteine 
residues that form disulphide bonds thought to stabilise it in the periplasm. It is 
currently the only AHL acylase known to have these. 
Rational mutagenesis has been used to switch the substrate specificity of PvdQ so 
that it could quench the Burkholderia quorum-sensing signal, C8-HSL (Koch et al., 
2014b). The Leu169Trp/Phe240Tyr variant of PvdQ degrades C8-HSL instead of 
3-oxo-C12-HSL. As single mutations, these variants had activity against both 
AHLs. In combination, activity against 3-oxo-C12-HSL was abolished and there 
was an increase in C8-HSL activity relative to the single mutants. Trp169 occupies 
part of the PvdQ hydrophobic pocket, reducing its volume. This brings the 
carbonyl carbon atom of C8-HSL closer to the Ser217 hydroxyl group. The 
hydroxyl group of Tyr240 is thought to interact with the amino side-chain of 
Trp169, holding PvdQ in an open conformation to bind C8-HSL. 
QuiP, the second P. aeruginosa PAO1 AHL acylase, was found when pvdQ 
knockout strains of P. aeruginosa PAO1 were shown to grow on 3-oxo-C12-HSL 
(Huang et al., 2006). Expression in E. coli also produced mostly unprocessed QuiP 
but the active protein still degraded AHLs. The third P. aeruginosa PAO1 AHL 
acylase discovered is termed HacB (Wahjudi et al., 2011). It had similar issues of 
expression in E. coli but active HacB could degrade AHLs as well as penicillin. P. 
syringae strain B728 has two AHL acylases, a secreted HacA and an intracellular 
HacB, which is similar to that of P. aeruginosa PAO1 (Shepherd and Lindow, 
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2009). The most recently discovered AHL acylase is the Pseudoalteromonas 
flavipulchra JG1 PfmA (Liu et al., 2017). 
AHL acylases discovered outside of the Pseudomonads include the Shewanella sp. 
strain MIB015 Aac (Morohoshi et al., 2008), which reduces biofilm formation 
when expressed in the fish pathogen V. anguillarum, the Ralstonia solanacearum 
GMI1000 Aac (Chen et al., 2009) and the Acidovorax sp. strain MR-S7 MacQ 
(Kusada et al., 2017) (Figure 1.8). MacQ degrades AHLs as well as antibiotics and 
is the second solved structure of a native AHL acylase. Anabaena sp. PCC7120 
AiiC was thought to have AHL acylase activity based on experiments with crude 
native cell extracts (Romero et al., 2008). However, these results were not clear or 
validated. The luminescence assay used measures AHL acylase activity as 
reduction in the amount of AHL, where a low luminescence indicates a smaller 
amount of AHLs present, due to degradation by the acylase. However, it does not 
indicate the production of HSL that is a result of the acylase reaction, which high 
performance liquid chromatography would. 
AHL acylases have also been found in Gram-positive bacteria. The Streptomyces sp. 
strain M664 AhlM (Park et al., 2005) is an extracellular AHL acylase that can also 
degrade penicillin.  Rhodococcus erythropolis W2 has also been shown to have AHL 
acylase activity but a corresponding protein has yet to be identified (Uroz et al., 
2005). QqaR is another AHL acylase found in the extremophile Deinococcus 
radiodurans (Koch et al., 2014a). 
Other microbial AHL acylases identified include the Ochrobactrum sp. A44 AiiO 
(Czajkowski et al., 2011), Acinetobacter sp. Ooi24 AmiE (Ochiai et al., 2014), an 
unnamed enzyme from Delftia sp. VM4 (Maisuria and Nerurkar, 2015) and 
Acinetobacter baumannii AidA (López et al., 2017). These acylases are predicted to 
have a different fold from N-terminal nucleophile hydrolases. 
While the physiological role of AHL acylases is unclear, it is thought that they are 
used to regulate the bacteria’s own quorum-sensing system, to compete against 
other bacteria that use AHL-based quorum sensing or to provide nutrients (Utari et 
al., 2017). AHL acylases occur in diverse microbes, have a range of activity against 
different AHLs as well as other substrates and can be used for quorum quenching. 
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1.3.3 Occurrence	of	resistance	to	quorum-quenchers	
The premise of quorum quenching is that it will inhibit processes that contribute to 
infections in humans without killing bacteria (Finch et al., 1998). This assumes that 
there would be low evolutionary pressure for bacteria to develop resistance to 
quorum quenchers (Cegelski et al., 2008; Uroz et al., 2009).  
It was speculated that resistance to quorum quenching could emerge (Defoirdt et 
al., 2010; Hong et al., 2012; García-Contreras, 2016). This may be due to variation 
already present in genes that contribute to quorum sensing, compensatory 
mutations, and/or the effect of the environment and individual variation on the 
fitness and interaction of bacteria in the biofilm community (Figure 1.1). The 
mechanisms by which resistance to quorum quenchers can develop are out of the 
scope of this thesis. 
Development of resistance to small molecule quorum quenchers has already been 
demonstrated in laboratory and clinical contexts. Maeda et al. (2012) show that P. 
aeruginosa can develop resistance to the small-molecule quorum quencher C-30 
(Hentzer et al., 2003). They did this by randomly mutating P. aeruginosa PA14 with 
transposons and growing the mutants on minimal media with adenosine to mimic 
clinical conditions that require quorum sensing. They found that mutants without 
the mexR and nalC genes were resistant to C-30. They also showed that existing 
clinical isolates without these genes were also resistant to C-30. The mexR gene 
negatively regulates the MexAB-OprM efflux pump (Chen et al., 2010), which 
exports 3-oxo-C12-HSL (Pearson et al., 1999) and a variety of antibiotics (Masuda 
et al., 2000). The nalC gene also negatively regulates this pump (Cao et al., 2004). 
Loss of these genes would allow expression of the pump to remove C-30. This 
shows that the ability to resist some forms of quorum quenching can develop in the 
laboratory and already exists in clinical situations. García-Contreras et al. (2013) 
also show that P. aeruginosa clinical isolates show different changes in virulence 
factors in response to exposure to C-30 and another small-molecule quorum 
quencher, 5-fluorouracil, demonstrating the effect of individual variation on 
resistance to quorum quenching. 
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Thus far, there has been no literature describing development of resistance to 
enzymatic quorum quenchers. More research is required to understand the specific 
contexts in clinical environments where resistance to quorum quenchers can 
develop, as well as how long this may take and strategies to delay development of 
resistance (Köhler et al., 2010). 
1.4 Glutaryl-7-aminocephalosporanic	acid	acylase	
To be a useful quorum-quencher, an AHL acylase must be easily purified for 
characterisation and eventual clinical application. Studies of Pseudomonad AHL 
acylases show that their protein yields tend to be poor (Shepherd and Lindow, 
2009). For this project, a related N-terminal nucleophile hydrolase, the GL7-ACA 
acylase was chosen to engineer quorum-quenching activity. This acylase has good 
heterologous expression in E. coli and purifies with a high yield (Kim et al., 2003). It 
is well characterised and has been engineered for new activities before (Otten et al., 
2002; Sio and Quax, 2004; Isogai and Nakayama, 2016). It also presented an 
opportunity to further understand the substrate specificities of different N-terminal 
nucleophile hydrolases. 
Also known as cephalosporin acylases, these enzymes are important for industrial 
production of antibiotics (Elander, 2003; Barber et al., 2004). The chemical 7-
aminocephalosporanic acid (7-ACA) forms the basic unit for many semi-synthetic 
β-lactam antibiotics. It used to be chemically synthesised, which was demanding 
and hazardous, but discovery of GL7-ACA acylases allowed for safer enzymatic 
routes (Matsumoto, 1992). 
The Pseudomonas sp. SY77 (PsSY77) GL7-ACA acylase hydrolyses GL7-ACA into 
glutaric acid and 7-ACA (Shibuya et al., 1981) in the final step of cephalosporin 
conversion to 7-ACA (Figure 1.9). 
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Figure 1.9 GL7-ACA hydrolysis. 
The PsGK16 strain was created by chemical mutagenesis of the PsSY77 strain 
(Ichikawa et al., 1981a) for better industrial 7-ACA production (Matsumoto, 1992). 
The amino acid sequences of the two acylases differ by only three residues that do 
not affect processing or catalysis (Lee et al., 1996). The PsGK16 GL7-ACA acylase 
has been well-researched to understand its formation and function (Kim et al., 
2003) while the PsSY77 GL7-ACA acylase has been engineered for novel activities 
(Otten et al., 2002; Sio et al., 2002). 
Like AHL acylases, GL7-ACA acylases are expressed as a polypeptide with a 
signal sequence, a small α subunit, a spacer and a larger β subunit from N- to C-
terminal (Lee et al., 1996). The signal sequence is required for export (Randall and 
Hardy, 1989) and once it is removed, the folded enzyme removes its own spacer by 
autocatalysis to become the active enzyme. This proceeds in two steps (Kim et al., 
2006; Cho et al., 2009). In the first step (primary processing), the first N-terminal 
residue of the β subunit, which is serine for both AHL and GL7-ACA acylases 
(Figure 1.8, Figure 1.10), acts as a nucleophile to hydrolyse the peptide bond 
between itself and the last C-terminal residue of the spacer. This is thought to 
change the conformation of the spacer, facilitating the second step of autocatalytic 
processing (secondary processing). Here, the peptide bond between the last residue 
of the α subunit and the first residue of the spacer is hydrolysed, leaving the active 
enzyme. 
The catalytic mechanism and substrate specificity of the PsSY77 and PsGK16 
GL7-ACA acylases are not fully addressed but a similar enzyme in Pseudomonas 
diminuta KAC-1 (PdKAC1) has been described (Kim et al., 1999). It shares 98% 
amino acid sequence identity and the same active site residues with the other two 
GL7-ACA acylases (Cho et al., 2009). Structures of the PdKAC1 GL7-ACA 
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acylase with and without GL7-ACA and the glutarate product have been solved 





Figure 1.10 Structure of GL7-ACA acylase. (A) PdKAC1 GL7-ACA acylase (PBD 
1JVZ). (B) Catalytic residues of PdKAC1 GL7-ACA acylase. Catalytic residues 
shown as sticks, carbon atoms in grey, nitrogen atoms in blue and oxygen 
atoms in red. Residues numbered by full-length sequence. 
The catalytic residues of GL7-ACA acylases are the same as those of AHL acylases 
(Figure 1.8, Figure 1.10B). The substrate-binding pocket is small with polar and 
hydrophobic residues to accommodate the glutaryl side-chain. Most interactions of 
GL7-ACA with the binding pocket are due to the glutaryl side-chain. 
The PsSY77 and PdKAC1 GL7-ACA acylases have been successfully engineered 
for activity against other substrates for antibiotic production (Table 1.1). 
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* Amide bonds of substrates shown in blue to highlight differences of side-
groups. # Variants with best activity in bold. 
 
The PsSY77 GL-7ACA acylase has been engineered to hydrolyse adipyl-7-
aminodesacetoxycephalosporanic acid to produce an alternate structural unit for β-
lactam antibiotics (Table 1.1) (Otten et al., 2002; Sio et al., 2002). Mutations such 
as Tyr178His and Phe375Leu allow binding of the longer adipyl chain. New 
catalytic residues were also identified. Mutation of Asn266 to serine or histidine 
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changes the position of Arg255, which then interacts with the adipyl side chain of 
adipyl-7-aminodesacetoxycephalosporanic acid. A Phe375Gly/Met174Ala/ 
Tyr178Val variant has also been engineered for activity against aculeacin A (Isogai 
and Nakayama, 2016). The PdKAC1 GL7-ACA acylase has been engineered for 
activity against cephalosporin C (Oh et al., 2003) (Table 1.1). The 
Tyr178Lys/Gln248Met/Phe375Gly variant has increased activity against 
cephalosporin C compared to the wild type. In all three studies, the mutated 
residues are smaller than the original ones. This is so that the binding pocket can 
accommodate longer or bulkier substrate side chains.  These studies show that 
GL7-ACA acylases are good templates for engineering new activities. 
1.6 Project	aims	
Overall, this project aimed to understand the specificity of AHL acylases so that 
they can be engineered as quorum-quenching enzymes to help combat P. aeruginosa 
PAO1 biofilm infections.  
The specific aims of this project were to: 
• To find and characterise a suitable template for engineering AHL acylase 
activity, 
 
• To develop a high-throughput screen to find new AHL acylases, 
 
• To generate and screen variants constructed from the template for AHL 
acylase activity, 
 
• To characterise new AHL acylase variants and test them against P. 
aeruginosa PAO1 biofilms 
Chapter 2 describes work carried out to find a template for engineering and to 
develop a high-throughput screen for AHL acylases. Chapter 3 describes the 
construction and screening of AHL acylase variants from the selected template 





























The first two aims of this project were to identify a template for engineering AHL 
acylase activity and to develop a screen to identify new AHL acylases. 
Proteins with high thermostability are often used as templates for engineering 
because they compensate for the destabilisation that occurs when mutations are 
introduced to confer new activities (Tracewell and Arnold, 2009; Martínez and 
Schwaneberg, 2013). Many thermostable enzymes are derived from thermophilic 
organisms that live at temperatures from 60 to 85 °C, such as the archaeon 
Sulfolobus solfataricus (Littlechild, 2015). Factors that contribute to protein 
thermostability depend on the organism, environment and the protein itself 
(Littlechild et al., 2013). Thermostable enzymes from S. solfataricus have been used 
for biotechnological applications (Raddadi et al., 2015). An AHL lactonase from S. 
solfataricus has been shown to retain activity in organic solvents and temperatures 
below zero (Rémy et al., 2016). Enzymes from S. solfataricus have also been 
expressed in and purified from E. coli (Kim, Mi-Sun et al., 2004; Park et al., 2008). 
Enzyme engineering can also be carried out using enzymes that already possess 
activity toward other substrates, possibly including the desired substrate. Therefore, 
creating variants active toward the desired substrate can be easier (Tracewell and 
Arnold, 2009). Many members of the N-terminal hydrolase family display activity 
towards several substrates (Oinonen and Rouvinen, 2000). The Streptomyces sp. 
strain M664 AhlM (Park et al., 2005) and P. aeruginosa PAO1 HacB (Wahjudi et al., 
2011) acylases degrade a broad range of AHLs as well as penicillin. The most 
recent example of a promiscuous acylase is the Acidovorax sp. strain MR-S7 MacQ, 
which has activity against many AHLs and β-lactam antibiotics (Kusada et al., 
2017). It is likely that other acylases may have such promiscuity, but have not been 
tested for it.  
It is also possible to engineer enzymes for activity against substrates that they have 
some or no activity upon (Tracewell and Arnold, 2009). This relies on the 
structural similarity of proteins rather than similarity in activity. One example is 
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the subtilisins from Bacillus amyloliquefaciens and Bacillus licheniformis. Both share the 
same structure and 69% sequence identity (Wells et al., 1987). Three substrate-
binding residues in the B. amyloliquefaciens subtilisin were mutated to the 
homologous residues of the B. lichenoformis subtilisin. This gave the B. 
amyloliquefaciens subtilisin a similar substrate specificity profile as the B. 
lichenoformis subtilisin. The three mutations represent only 1% of the amino acid 
sequence. Nuclear transport factor 2, involved in protein translocation across 
nuclear membranes, has also been previously mutated and given catalytic activity 
(Nixon et al., 1999). Nuclear transport factor 2 and scytalone dehydratase have 
similar structures but less than 20% sequence identity. By changing four residues in 
nuclear transport factor 2 and adding an extension to correctly position another 
catalytic residue, the variant of nuclear transport factor 2 gained weak activity 
against a scytalone analogue. 
Once libraries of variants are engineered from a chosen scaffold, high-throughput 
screens must be developed and optimised to quickly find enzymes with the desired 
function. A high-throughput method for screening AHL acylases did not exist at 
the time this project was begun. The most common method to assess AHL acylase 
activity has been biosensors, which are bacterial strains engineered to detect AHLs. 
These signals are converted to coloured products, luminescence or fluorescence 
(Rai et al., 2015). Biosensors detect a reduction of AHLs rather than the presence of 
reaction products. They are semi-quantitative, rely on cell growth and require long 
incubations to generate a signal. Chow et al. (2009) developed a method to detect 
AHL lactonases using E. coli biosensors that luminesce in the presence of AHLs 
(Winson et al., 1998; Lindsay and Ahmer, 2005). The biosensors are transformed 
with expression plasmids carrying AHL lactonase genes and spread on to agar 
plates containing the appropriate antibiotics, AHLs and isopropyl-beta-D-
thiogalactopyranoside (IPTG). When functional AHL lactonases are expressed in 
the biosensor, the AHLs are degraded and less luminescence is produced. 
Another method to detect AHL acylase activity is high-performance liquid 
chromatography (Morohoshi et al., 2008). It is quantitative and can identify 
reaction products but the process is time-consuming. Downstream processes 
affected by quorum sensing, such as the ability to produce virulence factors (Chen 
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et al., 2009; Koch et al., 2014b), are also used as a proxy to determine quorum 
quenching (de Kievit, 2009). However, quorum sensing regulates many 
overlapping processes and it is difficult to know whether the effect on the studied 
phenotype is directly due to quorum quenching (Parsek and Greenberg, 2005). 
In this chapter, two templates were considered for engineering AHL acylase 
activity, one from the extremophile archaeon S. solfataricus for its potential 
thermostable properties and the other from industrial antibiotic production 
(Ichikawa et al., 1981b), for its structural similarity to AHL acylases. Two methods 




The SSO1638 gene from S. solfataricus (She et al., 2001) was initially chosen as the 
template to engineer acyl-homoserine lactone acylase activity for its potential 
thermostability (Littlechild, 2011). However, nothing is known about it.  
SSO1638 is predicted to be a member of the penicillin amidase family (PF01804), 
which includes the penicillin/GL-7-ACA/AHL/aculeacin-A acylases (IPR002692) 
(Finn et al., 2016). Since no structure of SSO1638 exists, homology models were 
made with Phyre2 (Kelley et al., 2015) and SWISS-MODEL (Biasini et al., 2014) 
using the full-length sequence of SSO1638 (Figure 2.1). Both servers selected 3S8R 
(previously 1OQZ), the PsSY77 GL7-ACA acylase structure, as the template with 
which to build the model. The accuracy of the homology model being built 
depends on sequence identity (Tramontano, 1998). While SSO1638 and the 
PsSY77 GL7-ACA acylase share only 16% sequence identity, both models covered 
77% of the SSO1638 sequence. The SWISS-MODEL homology model had an 
average global model quality estimation of 0.47 (range 0-1, where a higher score is 
higher reliability) and a QMEAN Z-score of -6.59 (a score of less than  -4.0 
indicates very low quality). However, the Phyre2 homology model had 100% 
confidence in the probability that the SSO1638 sequence shared true homology 
with the PsSY77 GL7-ACA acylase structure. A useful model can be made with 
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sequences of low identity using remote homology detection techniques, such as 
that of Phyre2 (Kelley and Sternberg, 2009). Therefore, it is very likely that the core 
of modelled protein shares the same fold as the structure used even if the homology 





Figure 2.1 SSO1638 homology models. (A) SWISS-MODEL. (B) Phyre2. Models 
shown on the left, catalytic residues on the right. Residue numbering based on 
full-length amino acid sequence. Carbon atoms shown in marine and cyan, 
respectively, nitrogen atoms in blue, oxygen atoms in red. 
SSO1638 shows similar active site residues to PvdQ and the PsSY77 GL7-ACA 
acylase (Figure 2.1, Figure 1.8, Figure 1.10). Four of the five catalytic residues are 
conserved but SSO1638 has Thr368 where Val286 and Val268 are for PvdQ and 
the PsSY77 GL7-ACA acylase. The main-chain amine group of these residues is 
involved in processing and catalysis, rather than the side group (Kim et al., 2000; 
Kim et al., 2003). The similarity in active site suggests that SSO1638 can hydrolyse 
amide bonds the way these two acylases do.  
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Based on this, expression of SSO1638 was attempted in E. coli. Several E. coli 
strains were transformed with the pET20b expression plasmid carrying the 
SSO1638 gene for protein over-expression trials (Figure 2.2). 
  
  
Figure 2.2 SSO1638. (A) Expression plasmid pET20b SSO1638 His6. Gene in 
purple; subunits, spacer and His6 tag in grey; gene encoding enzyme for 
ampicillin resistance in green. (B) Full-length amino acid sequence. Signal 





No expression of SSO1638 was observed in BL21(DE3), C41(DE3) or 
Rosetta(DE3) (Figure 2.3). 
 
Figure 2.3 Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) of putative SSO1638 protein expression trials. (A) Expression in BL21 
(DE3). For both sets, lanes are pre-induction, post-induction, total protein and 
soluble protein. (B) Expression in C41 (DE3). Lanes are pre-induction, 24 hours 
post-induction, 40 hours post-induction, total protein and soluble protein. (C) 
Expression in Rosetta (DE3). Lanes as for (B). Black arrow shows predicted size 
of full-length protein (91 kDa), blue arrow shows predicted size of β subunit (60 
kDa) and red arrow shows predicted size of α subunit (29 kDa). 
BL21(DE3) is typically used as the initial strain for expressing proteins from 
plasmids with T7 promoters such as pET20b. C41(DE3) was used because 
SSO1638 was difficult to express in BL21(DE3) (Dumon-Seignovert et al., 2004). 
Rosetta(DE3) was used because the SSO1638 gene contains tRNAs that are rarely 
used in E. coli such as AUA for isoleucine, CUA for leucine, AGA, AGG and 
CGA for arginine (Novy, 2001). These are spread out across the gene and two 
occur in tandem in two parts of the gene. SSO1638 was not expressed in either of 
these strains.  
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SSO1638 was abandoned as a template for engineering AHL acylase activity 
because it could not be expressed. The PsSY77 GL7-ACA acylase, which provided 
the structure to model SSO1638, was used instead. 
 
2.2.2 Cloning	and	expression	optimisation	of	PsSY77	GL7-ACA	acylase		
The full-length PsSY77 GL7-ACA acylase gene was codon-optimised for 
expression in E. coli and ordered from ATUM (Figure 2.5A). The gene was then 
sequenced to ensure that it was correct. Gibson assembly was used to insert the 
gene into the pET20b plasmid (Gibson et al., 2009). First, the gene and plasmid 
were amplified by PCR separately (Figure 2.4, Table 6.3). This was done to 
remove the signal sequence of the PsSY77 GL7-ACA acylase, which is not 
necessary for expression in E. coli (Lee and Park, 1998), and to add a His6 tag at the 




Figure 2.4 PCRs to assemble expression plasmid pET20b –ss PsSY-77 GL7-ACA 
acylase His6 by Gibson assembly. (A) PCR and primers for removal of signal 
sequence and addition of His6 tag for full-length PsSY-77 GL7-ACA acylase gene 
insert. (B) PCR and primers for removal of signal sequence and addition of His6 
tag for pET20b plasmid vector. Gene shown in purple, plasmid shown in black 
and primers shown in blue (refer to Table 6.3). 
 
The PCR leaves complementary ends on the amplified gene and plasmid. These 
are then degraded by an exonuclease to leave sticky ends. The sticky ends then 
anneal to each other and DNA polymerase fills the gaps with nucleotides. Lastly, 





Figure 2.5 Plasmids containing PsSY77 GL7-ACA acylase. (A) Cloning plasmid 
pJ201 PsSY-77 GL7-ACA acylase. (B) Expression plasmid pET20b –ss PsSY-77 
GL7-ACA acylase His6. For both plasmids, gene in purple, features in grey, 
genes encoding enzymes for kanamycin and ampicillin resistance in green. 
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BL21(DE3) cells were then transformed with the pET20b PsSY-77 –ss GL7-ACA 
acylase His6 plasmid by electroporation. Trials were carried out to determine the 
best media and temperature conditions for enzyme over-expression (Figure 2.6). I 
used Lysogeny broth (LB), Terrific broth (TB) and Terrific broth auto-induction 




Figure 2.6 SDS-PAGE of BL21(DE3) pET20b PsSY77 –ss GL7-ACA acylase His6 
expression trials. For each temperature, lanes are pre-induction, post-induction, 
total protein and soluble protein. (A) Expression in LB. (B) Expression in TB. (C) 
Expression in TB-AIM. Black arrow indicates unprocessed enzyme, black box β 
subunit and blue arrow lysozyme. 
All conditions showed the presence of unprocessed PsSY77 GL7-ACA acylase at 
~75 kDa in the total fraction. However, only LB and TB-AIM at 18 °C showed the 
processed β subunit at 50 kDa in the soluble fraction. The prominent bands at 15 
kDa were identified by mass spectrometry (Section 6.4.6) to be lysozyme that was 
used for cell lysis and not the α subunit of the acylase. I chose to use TB-AIM and 




After expression under optimised conditions, the His6-tagged PsSY77 GL7-ACA 
acylase was purified using immobilised metal ion affinity chromatography with 
cobalt resin (Figure 2.7). 
 
Figure 2.7 SDS-PAGE of PsSY77 –ss GL7-ACA acylase His6 purification. Lanes 
are pre-induction, post-induction, total protein, soluble protein, washes 1-3, 
protein ladder, elution fraction. Black arrow indicates unprocessed enzyme, 
blue arrow β subunit, red arrow α subunit. Box highlights degradation products. 
The PsSY77 GL7-ACA acylase occurs as the 78 kDa full-length unprocessed band 
in the total fraction. The enzyme processes itself over the course of the purification, 
yielding the 59 kDa β subunit and 18 kDa α subunit. These were confirmed by 
mass spectrometry. The elution fractions also show the presence of some 
unprocessed enzyme and impurities. Mass spectrometry showed that the impurities 
were due to degradation of the enzyme. 
A screen was then carried out to determine the best buffer in which to store the 
PsSY77 GL7-ACA acylase (Figure 2.8). Based on this screen, the enzyme was 
stored in 50 mM potassium phosphate, 200 mM sodium chloride, 10% glycerol, 
pH 7.0 (pH 7 phosphate high salt) as it matched the buffers used for purification. 
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Figure 2.8 PsSY77 GL7-ACA acylase buffer screen. Buffers sorted from highest 
to lowest melting temperature. Final storage buffer used highlighted in blue. 
Size exclusion chromatography was used to characterise the quaternary 
conformation of the PsSY77 GL7-ACA acylase (Figure 2.9). This was done using 
the Superdex 200 10/300 GL column, which has a total volume (Vt) of 24 mL. The 
PsSY77 GL7-ACA acylase elutes at a volume (Ve) of ~12.8 mL. Calibration 
standards were run on the column using the same buffer and protocol. The void 
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Figure 2.9 Determination of PsSY77 GL7-ACA acylase quaternary conformation. 
(A) Size exclusion chromatography trace for PsSY77 GL7-ACA acylase. Blue bar 
indicates fractions used for SDS-PAGE. (B) SDS-PAGE of elution fractions, blue 
arrow β subunit, red arrow α subunit. (C) Size exclusion chromatography trace 
for calibration standards. A, gamma globulin 158 kDa; B, ovalbumin, 44 kDa; C, 
myoglobin, 17 kDa; D, vitamin B12, 1.3 kDa. (D) Calibration curve. 
To determine the molecular mass of the acylase, the partition coefficients (Kav) of 
the standards and the acylase must be calculated using the equation:  




Using the linear equation derived from plotting Kav against the log of the molecular 
mass of each known standard, the theoretical size of the acylase was calculated to 
be ~151 kDa. This corresponds to a dimer made up of two enzyme heterodimers, 
which is 154 kDa. This is consistent with GL7-ACA acylases from other 
Pseudomonas strains (Battistel et al., 1998; Kim et al., 2003). 
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The PsSY77 GL7-ACA acylase was assayed for activity against GL7-ACA as 
performed in Sio et al. (2002) and showed consistent values (Table 2.1). 
Table 2.1 Kinetic parameters of PsSY77 GL7-ACA acylase against GL7-ACA. 
 experimental* Sio et al. (2002) 
Km (µM) 59 ± 19 80 
kcat (s-1) 8 ± 2 8 
*measured at 37 °C in 20 mM potassium phosphate pH 7 as done by Sio et al. (2002). 
The enzyme has maximum activity at 50 °C and retains activity at 37 °C for up to 
ten days in 20 mM potassium phosphate pH 7 (Figure 2.10).  
(A) (B) 
  
Figure 2.10 Native activity of PsSY77 GL7-ACA acylase. (A) Effect of 
temperature on activity. (B) Activity at 37 °C over time. 
Using the method as optimised in Section 2.2.4, the enzyme was assayed against 
C4-, C6-, C8-, C10-, C12- and 3-oxo-C12-HSL (Appendix Figure 1). No activity 
was detected against any of these AHLs, consistent with Sio et al. (2006). 
With the selection and characterisation of a template for engineering, a high-




Two methods using luminescence and fluorescence were tested for high-
throughput screening of AHL acylases. 
AHL-responsive luminescent biosensors previously used for high-throughput 
screening of AHL lactonases (Chow et al., 2009) can be modified for screening 
AHL acylases. The biosensors can be transformed with an expression plasmid 
library of AHL acylase variants (Figure 2.11). These can then be spread on to a 
large agar plate containing the appropriate antibiotics, AHLs and IPTG. The 
AHLs will bind to the AHL receptor, which is transduced into a luminescent 
signal. The IPTG is used to induce expression of AHL acylases. Colonies can be 
imaged and the luminescence of each colony will be an indication of AHL acylase 
activity. Those with low luminescence will be functional AHL acylases as the 
AHLs have been degraded. 
 
Figure 2.11 AHL biosensor containing AHL acylase construct. 
Lindsay and Ahmer (2005) constructed three luminescent biosensors to detect 
different AHLs. Each has an accompanying negative control that does not contain 
the AHL receptor. An initial test was carried out using JLD271 pAL103 to detect 
the activity of the P. aeruginosa PAO1 HacB AHL acylase, the positive control for 
the AHL acylase screens (Figure 2.12). Loss of luminescence indicated that HacB 
has acylase activity against C8-HSL but not against C6-HSL. It is known however 
that HacB has activity against both AHLs, although it is more active against C8-
HSL (Wahjudi et al., 2011). This method therefore will not detect low-activity 
variants that may be derived from a template with no prior AHL acylase activity. 
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Figure 2.12 Initial test for AHL acylase activity using AHL biosensors. 
To make the luminescence method more sensitive, the biosensors were grown as 
liquid cultures in 96-well plates in the presence of AHLs and their luminescence 




Figure 2.13 Biosensor luminescence in response to AHLs over 6 hours. (A) 
JLD271 pAL101 against C4-HSL. (B) JLD271 pAL103 against C6-HSL. (C) JLD271 
pAL103 against C8-HSL. (D) JLD271 pAL103 against C10-HSL. (E) JLD271 
pAL105 against C12-HSL. (F) JLD271 pAL105 against 3-oxo-C12-HSL. Negative 
control EA, ethyl acetate used as AHL solvent. RLU represents relative 
luminescence units. 
Although the different AHLs were used at the same amount, the biosensors 
produced different relative light units at the same end point. The pAL103 biosensor 
also detected C10-HSL instead of the pAL105 biosensor, which is different from 
what was reported before (Winson et al., 1998). This would make standardising 
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high-throughput screens more difficult. Each AHL would require its own screen 
plate for each library and endpoints would also need to be optimised for each AHL 
for best signal-to-noise ratio. This would use more time and consumables than 
necessary.  
2.2.5 	Development	of	a	high-throughput	AHL	acylase	screen	using	fluorescence	
Due to the complications of handling biosensors, an alternative method was 
developed for a high-throughput screen for AHL acylases. For this, two things in 
particular were optimised: substrate concentrations and the ability to detect signals 
that define true AHL acylases. 
The AHL substrates ranging from C4-HSL to 3-oxo-C12-HSL are increasingly 
hydrophobic due to the increasing length of the fatty acid chain. C8-, C10-, C12- 
and 3-oxo-C12-HSL require organic solvents while C4- and C6-HSL are soluble in 
water. Trials were carried out to determine the solubility of C8-, C10-, C12- and 3-
oxo-C12-HSL in DMSO. These four AHLs were soluble in 100% DMSO at 30 
mM, could be stored at -20 °C and thawed as needed. The solubility of these stocks 
in the screen buffer, 100 mM potassium phosphate pH 7.0, were then determined. 
The four AHLs were soluble up to 200 µM (0.67% DMSO) in this buffer when 
dissolved from the 30 mM stock. To standardise the screening protocol, C4- and 
C6-HSL were made up in a similar manner as the others.  
Organic solvents can affect protein folding even at the low concentrations typically 
used for dissolving substrates for screening (Tjernberg et al., 2006). As little as 2% 
DMSO reduces the melting temperature of the PsSY77 GL7-ACA acylase by 2 °C 
(Figure 2.14). Therefore, a low DMSO concentration balanced with a soluble 
AHL concentration was important to find. 
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Figure 2.14 Effect of DMSO concentration on thermostability of PsSY77 GL7-
ACA acylase. Tm represents protein melting temperature. 
The ability to detect AHL acylase activity in a high-throughput screen was then 
optimised. High-throughput screening to find PsSY77 GL7-ACA acylase variants 
active against novel substrates previously used a reagent called fluorescamine 
(Otten et al., 2002; Sio et al., 2002). It reacts with primary amines to produce a 
fluorescent derivative (Reyes et al., 1989). HSL, the common product of all AHL 
degradation by acylases, is also a primary amine. Therefore, a screen using 
fluorescamine to detect AHL acylases was developed (Figure 2.15). 
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Figure 2.15 Outline of the high-throughput screen. (A) Degradation of any AHL 
by an AHL acylase, producing a fatty acid and HSL. (B) Reaction of HSL with 
fluorescamine, producing a fluorescent derivative. Bond breakage and 
formation highlighted in blue. 
 
AHL stability under the screening conditions at 30 °C over 24 hours was first 
checked. The screen was intended for a long period to maximise its ability to find 
low-activity variants. A low temperature was chosen to compensate for potentially 
destabilising mutations in the variants (Tokuriki and Tawfik, 2009). It is known 
that AHLs degrade depending on pH and temperature, forming acyl-homoserine 
(Yates et al., 2002). These acyl-homoserine products may result in false positives in 
the screen. At a final concentration of 200 µM, the AHLs do not produce 
fluorescent signals until 24 hours (Figure 2.16). However, these are not significant 
relative to the background fluorescence from controls under the chosen screening 
conditions (Figure 2.19). 
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Figure 2.16 AHL degradation under chosen screening conditions. RFU 
represents relative fluorescence units. 
The pH under which the reaction of fluorescamine and a primary amine occurs 
affects the fluorescence of the derivative (Udenfriend et al., 1972). Therefore, pH 
conditions for the reaction of HSL with fluorescamine were optimised (Figure 
2.17). Citrate-phosphate buffers were used in these experiments as pH can be 
changed without changing buffer composition. Acetone and acetonitrile were also 






Figure 2.17 Effect of different conditions on the signal intensity of HSL-
fluorescamine derivative. (A) pH and solvent type. (B) Acetone concentration. 
RFU represents relative fluorescence units. 
HSL produces a consistent signal over pH 5 to 8 when it reacts with fluorescamine 
dissolved in acetone but the signal decays with increasing pH when HSL reacts 
with fluorescamine dissolved in acetonitrile (Figure 2.17A). This experiment used 
the Bantan-Polak et al. (2001) method with a final solvent concentration of 30%. 
However, the Sio et al. (2002) method uses a final solvent concentration of 10%. It 
was found that a final acetone concentration of 10% produces a higher signal 
compared to 30% (Figure 2.17B). Based on these experiments, I chose to use 
fluorescamine at a final concentration of 0.03% dissolved in acetone at a final 
concentration of 10% and in a pH 7 buffer for screening. 
The screen is used with His6-tagged variants from 96-well cobalt resin purification 
(Section 6.5.2). This uses imidazole, a secondary amine, to elute proteins 
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(Bornhorst and Falke, 2000), which may interfere with the reaction of HSL with 
fluorescamine. 
 
Figure 2.18 HSL standard curve. (A) Standard curve up to 40 nmol HSL. (B) 
Blow-up of standard curve up to 5 nmol HSL. HSL only shown in blue, HSL with 
30 µmol imidazole shown in red. RFU represents relative fluorescence units. 
At 30 µmol, imidazole does not significantly interfere with the reaction of HSL 
with fluorescamine (Figure 2.18). With no HSL present, 30 µmol imidazole 
produces ~3000 RFU. However, 0.5 nmol HSL produces a signal of ~7000 RFU 
in the presence of 30 µmol imidazole and is distinguishable from this background 
fluorescence. The final amount of imidazole in the screen was 1.5 µmol so there 
was no significant background signal in the screen. 
Finally, the optimised screen was tested against the library controls (Figure 2.19):  
• E. coli C41(DE3), the expression strain for HacB,  
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• E. coli C41(DE3) pD441 PaHacB His6, the AHL acylase positive control 
expressing HacB (Wahjudi et al., 2011), 
• E. coli BL21 (DE3) pET20b, a vector-only control, and 
• E. coli BL21 (DE3) pET20b PsSY77 –ss GL7-ACA acylase His6, the 
template enzyme for engineering AHL acylase activity. 
Each well of each screen has 200 µL. This is made up of 10 µL elution fraction 
(which contains 1.5 µmol imidazole) and 190 µL AHLs to a final substrate 
concentration of 200 µM and final DMSO concentration of 0.67%. Screen plates 
were incubated at 30 °C for 24 hours with 100 rpm shaking. Twenty-four hours 
later, a 200 µM standard of HSL or 7-ACA was made up and added to the relevant 
plate. Twenty-five µL fluorescamine made up to 0.3% in 100% acetone was added 
to each well. The final concentrations were 0.033% fluorescamine and 11% 














Figure 2.19 Testing optimised screen. (A) C12- and 3-oxo-C12-HSL. (B) C8- and  
C10-HSL. (C) C4- and C6-HSL. (D) DMSO. (E) GL7-ACA. (F) Representative SDS-
PAGE gel of elution fractions. B, blank; 1, E. coli C41(DE3);  2, E. coli C41(DE3) 
pD441 PaHacB His6; 3, E. coli BL21 (DE3) pET20b; 4, E. coli BL21 (DE3) pET20b 
PsSY77 –ss GL7-ACA acylase His6. RFU represents relative fluorescence units. 
For the gel, black arrow indicates the β subunit of HacB; blue arrow, β subunit of 
GL7-ACA acylase; red arrow, α subunit of GL7-ACA acylase. 
For the C12- and 3-oxo-C12-HSL and the C8- and C10-HSL screens, the HacB 
positive control shows a clearly distinguishable signal from the C41(DE3) control. 
However for the C4- and C6-HSL screen, HacB shows a wide spread of signal. 
HacB has weak activity against C6-HSL and no activity against C4-HSL (Wahjudi 
et al., 2011). The vector-only and PsSY77 GL7-ACA acylase controls are not 
 49 
distinguishable from each other, showing that the PsSY77 GL7-ACA acylase does 
not have AHL acylase activity. From the screen with DMSO only, background 




Although the SSO1638 acylase could not be expressed, the homology modelling 
provided the PsSY77 GL7-ACA acylase as a template for engineering. This 
enzyme was expressed and purified easily (Figure 2.6, Figure 2.7). 
Auto-induction media was chosen for expression of the PsSY77 GL7-ACA acylase 
because it does not require separate addition of an inducer, making it suitable for 
growing libraries of variants in small volumes (Studier, 2005). Auto-induction 
media contains glucose and lactose, which act as carbon sources for the bacteria. E. 
coli will first use glucose to grow (Studier, 2005). Once the bacteria use up the 
glucose, they begin to use lactose. It is converted to allolactose and induces protein 
expression in the same way as IPTG. Bacteria can also grow to high densities in 
auto-induction media, leading to higher protein yields.  
The enzyme was not completely pure when purified by gravity flow using cobalt 
resin. The impurities were due to degradation of the enzyme and were not removed 
by size exclusion chromatography. This is consistent with Sio et al. (2002), who 
carried out further purification steps and with Li et al. (1999), who purified the 
enzyme with a His6 tag. Since this was the case, no further attempts were made to 
improve the purity of the PsSY77 GL7-ACA acylase. 
The PsSY77 GL7-ACA acylase is a robust scaffold for engineering as shown by the 
buffer screen and activity assays against GL7-ACA (Figure 2.8, Figure 2.10). It is 
a dimer made up of two enzyme heterodimers (Figure 2.9). Dimerisation is 
important for acylase activity. Battistel et al. (1998) previously showed that 
monomers of the Pseudomonas sp. NCIMB 40474 GL7-ACA acylase are less active 
against GL7-ACA than the dimer. Dimers were dissociated using concentrations of 
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guanidium hydrochloride that were not denaturing and with low pH. It is likely 
that an increase in temperature would have the same effect, where dimer 
dissociation causes a loss of activity prior to protein unfolding. 
2.3.2 Development	of	a	high-throughput	AHL	acylase	screen	
A high-throughput screen needed to be developed because one did not exist to 
identify AHL acylases. 
The screen was carried out in the Clariostar microplate reader to measure 
fluorescence. The Clariostar has a detection limit of 260000 arbitrary units and 
maximum detection is typically set at 90% of this value. However, a known 
amount of fluorescent compound must be associated with this set value. The AHL 
substrates used in the acylase screen were at a final concentration of 200 µM, 
which is 40 nmol in 200 µL, the final volume per well of each screen. Assuming 
there is complete enzymatic hydrolysis of AHL to HSL, a maximum of 40 nmol 
HSL will be present. Therefore, 40 nmol HSL was associated to the set detection 
value of the Clariostar and used to optimise conditions for signal detection (Figure 
2.17). A 40 nmol HSL standard was included in each AHL screen to be associated 
to the set detection value and to calibrate the amount of HSL in each screen sample 
to arbitrary units. All samples were detectable on the Clariostar as it was unlikely 
that any sample would result in complete conversion of AHL to HSL. 
Variant library purification was necessary because new AHL acylase variants 
derived from mutation of the PsSY77 GL7-ACA acylase would likely have low 
activity because it has no prior AHL acylase activity. Cell lysates also contain 
many amines that would likely interfere with low HSL signals when using 
fluorescamine to detect them. 
The screens were optimised so that they could be carried out directly in 96 black-
well plates and measured immediately after adding fluorescamine. The Sio et al. 
(2002) method required aliquoting of samples into plates containing the required 
buffer, adding fluroescamine and incubating for an hour before measurement. A 
new high-throughput method for screening quorum-quenching enzymes was 
developed by Last et al. (2016) during the course of this project. Homoserine, which 
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derives from autohydrolysis of HSL, reacts with calcein and fluorescence can then 
be measured from that derivative. The screen I developed with fluorescamine can 
detect HSL in the nanomolar range (Figure 2.18) while the Last et al. (2016) screen 
is sensitive in the micromolar range. Imidazole also strongly quenches fluorescence 
of calcein, while it does not affect the fluorescence obtained with fluorescamine 
significantly. 
A robust template for engineering AHL acylase activity was chosen and a sensitive 






























The third aim of this project was to engineer AHL acylase activity into the chosen 
scaffold, the PsSY77 GL7-ACA acylase. 
The goals of enzyme engineering include improving activity toward a substrate, 
developing activity toward new substrates or increasing the enzyme’s stability in 
extreme conditions such as temperature, pH, salinity and organic solvents 
(Kazlauskas and Bornscheuer, 2009; Bornscheuer and Kazlauskas, 2011). The 
choice of mutagenesis strategy depends on the goal to be achieved and the 
information available about the enzyme (Kazlauskas and Bornscheuer, 2009). The 
type of screen or selection carried out must also be considered to ensure there is 
sufficient throughput while reducing the time and effort required to find a 
functional variant.  
Mutagenesis can be carried out using random approaches, rational ones, or a 
combination of both. Random mutagenesis approaches are used when little is 
known about the structure and function of the enzyme to be mutated. These 
methods include chemical mutagenesis, mutator strains, error-prone PCR and 
DNA shuffling (Labrou, 2010). They allow exploration of the enzyme sequence 
and often find mutations that cannot be predicted. Using error-prone PCR, Kim, 
Young-Wan et al. (2004) found two mutations more than 5 Å away from the active 
site of the glycosynthase they engineered, which increased the types of substrates 
the enzyme can use. With the E. coli mutator strain, XL1 Red, Mendonça and 
Marana (2011) created variants of a β-glucosidase with altered substrate specificity 
and found that most of the mutations were about ~20 Å away from the active site. 
Multiple sequence alignments and homology models using related enzymes also 
help to provide more information about the enzyme to be engineered.  
On the other hand, rational design is used when information such as structures of 
the enzyme that include substrates and/or inhibitors, and kinetic data are available. 
The active site and other target areas for engineering can then be investigated and 
predictions can be made about which residues to change to achieve the desired 
effect. Shi et al. (2007) compared two structures of transcarbamylases and found 
that changing Glu92 of the N-acetylornithine transcarbamylase to proline changed 
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the enzyme to a N-succinylornithine transcarbamylase. Changing from proline to 
glutamate also caused the N-succinylornithine transcarbamylase to become a N-
acetylornithine transcarbamylase. 
Random and rational mutagenesis approaches can also be combined. They can be 
used in parallel and variants derived from each method can be compared (Ye et al., 
2012; Dror et al., 2014). Another way to combine them is through saturation 
mutagenesis (Wells et al., 1985). This is where positions in an enzyme are chosen 
and mutated randomly to other amino acids using degenerate codons, such as 
NNN, NNK and NNS, which represent different codon degeneracies (Wells et al., 
1985) (Table 3.1).  
Table 3.1 Forms of site-saturation mutagenesis. 
 codons amino acids stop 






32 1 96 
NNS 
22c 22 0 66 
 
 
For saturation mutagenesis, the final amino acid distribution of the library is an 
important consideration. An ideal library for one mutated residue would be an 
equal proportion of all other 19 amino acids and no stop codons introduced. NNN 
uses all 64 codons for 20 amino acids, thus some amino acids are coded by more 
than one codon, e.g. arginine and serine that have six, resulting in a bias in the 
amino acid distribution. It also requires a large number of variants to be tested to 
have high sequence coverage (Reetz et al., 2008). This means that for one mutated 
residue, 192 variants is the minimum number required to ensure that the 
probability that all possible amino acid variation is sampled is 95%. NNK and 
NNS mutagenesis methods reduce the number of degenerate and stop codons 
(Table 3.1) but still require testing a large number of variants. Kille et al. (2012) 
developed the “22c-trick”, where 22 codons code for 20 amino acids and no stop 
codons are present (Table 3.1). This is closer to the ideal proportion for amino 
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acids in a site-saturation mutagenesis library compared to the other forms of codon 
degeneracy. 
Iterative saturation mutagenesis also combines rational and random mutagenesis 
techniques (Reetz and Carballeira, 2007) (Figure 3.1). In the first round, single 
residues are mutated using saturation mutagenesis until a variant with desired 
activity is found (step #1). This variant is then used as a template for a second 
round of saturation mutagenesis and so on, producing the iterative cycle (step #n). 
Each step is intended to incrementally improve the desired property of the enzyme 
(Tracewell and Arnold, 2009). This can be achieved because each step of iterative 
saturation mutagenesis allows introduction of new mutations at a different 
position. Han et al. (2013) used iterative saturation mutagenesis to engineer a 
cyclodextrin glycosyltransferase to accept maltodextrin as a substrate rather than 
cyclodextrins. Four steps of site-saturation mutagenesis were used to create a 
variant that was 84% more active with maltodextrin than the wild type. 
 
Figure 3.1 Iterative saturation mutagenesis. Adapted from Reetz and Carballeira 
(2007). Green ticks indicate variants with activity, red crosses indicate variants 
with no activity. 
This chapter describes the choice of mutagenesis strategy to engineer AHL acylase 
activity into the chosen scaffold, the PsSY77 GL7-ACA acylase, selection of 
residues for mutagenesis, construction of variant libraries based on these choices 




Several mutagenesis methods have been used to engineer new activities into the 
PsSY77 GL7-ACA acylase for substrates similar to GL7-ACA (Section 1.4, Table 
1.1). To find variants active against adipyl-7-aminodesacetoxycephalosporanic 
acid, Sio et al. (2002) randomly mutated parts of the α subunit by error-prone PCR 
followed by site-saturation mutagenesis on the positions that showed activity. 
Otten et al. (2002) carried out error-prone PCR on the β subunit instead. For both 
sets of variants, selection on agar with a substrate similar to adipyl-7-
aminodesacetoxycephalosporanic acid was first used to find functional variants. 
For engineering activity against cephalosporin C, Oh et al. (2003) used iterative 
saturation mutagenesis informed by modelling of cephalosporin C into the GL7-
ACA acylase structure (Kim and Hol, 2001). More recently, computational 
modelling has been used to make site-directed mutations in GL7-ACA acylase for 
activity towards cephalosporin C (Eldarov et al., 2014) and aculeacin A (Isogai and 
Nakayama, 2016). 
The PsSY77 GL7-ACA acylase is a large protein with 720 amino acids. Assuming 
random mutagenesis was used with a mutation rate of four amino acid 
substitutions made randomly over the whole protein, this would result in 160,000 
variants to be screened. The screen developed accommodates one 96-well plate of 
variants against five substrate plates at a time (Section 2.2.4, Figure 2.19). Some of 
the PsSY77 GL7-ACA acylase residues are required for the acylase to process itself 
and form dimers to be fully functional (Battistel et al., 1998; Kim et al., 2000). Many 
mutants will be impaired in these abilities if a random approach was used, reducing 
the number of potentially functional mutants. Time constraints and the vast 
number of mutants generated from random mutagenesis would mean that the 
probability of finding a functional variant would be low (Martínez and 
Schwaneberg, 2013). 
Iterative saturation mutagenesis was chosen to engineer AHL acylase activity into 
the PsSY77 GL7-ACA acylase. Hotspots for substrate binding can be identified 
and randomised without requiring knowledge of the specific type of residue 
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necessary to give AHL acylase activity. The processing and catalytic mechanism of 
the protein also will not be damaged.  
3.2.2 Choosing	PsSY77	GL7-ACA	acylase	residues	for	mutagenesis	
To engineer AHL acylase activity, substrate-binding residues were first identified in 
the template structure, the PsSY77 GL7-ACA acylase and the AHL acylase guide 
structure, PvdQ. All modelling in this section was carried out using PyMOL 
(Version 1.8, Schrödinger, LLC). The native substrate GL7-ACA was modelled 
into the PsSY77 GL7-ACA acylase (PDB 1OR0) (Kim et al., 2003) (Figure 3.2). 
The AHL acylase PvdQ has several structures of it solved (Appendix Table 1). 
However, none of them were solved with AHLs present but three were solved 
containing the fatty acid products, octanoic, dodecanoic and 3-oxododecanoic 
acids (PDB 3L91, 2WYD and 2WYC , respectively) (Bokhove et al., 2010; Drake 
and Gulick, 2011). These fatty acids were modelled into the PvdQ structure (PDB 
2WYC) and it was found that all three bind to the PvdQ active site in the same 
area (Figure 3.2). 
 
To determine substrate-binding residues that can be mutated to confer AHL 
acylase activity in the template enzyme, 3-oxododecanoic acid from the PvdQ 
structure (PDB 2WYC) was modelled into the PsSY77 GL7-ACA acylase structure 
(PDB 1OR0). This was because 3-oxododecanoic acid is the acylase reaction 
product from the P. aeruginosa PAO1 quorum-sensing signal 3-oxo-C12-HSL. 
PsSY77 GL7-ACA acylase residues up to 5 Å away from 3-oxododecanoic acid 






Figure 3.2 Comparison of acylase active sites. (A) PsSY77 GL7-ACA acylase 
active site with substrate GL7-ACA. (B) PvdQ active site with different fatty acid 
products. (C) PsSY77 GL7-ACA acylase active site with 3-oxo-dodecanoic acid. 
Carbon atoms of catalytic residues shown in grey sticks. Carbon atoms of GL7-
ACA-binding residues and GL7-ACA in forest and light pink, respectively. 
Carbon atoms of AHL-binding residues in green, octanoic acid in magenta, 
dodecanoic acid in cyan, 3-oxo-dodecanoic acid in yellow, respectively. 
Nitrogen atoms in blue and oxygen atoms in red. Residues labelled according to 
full-length sequence. 
Although the two acylases share only 24% sequence identity, the structures of 
PvdQ and the PsSY77 GL7-ACA acylase aligned with a root mean square 
deviation of 2.2 Å. PvdQ has a deep pocket that accommodates long fatty acid 
chains while the PsSY77 GL7 acylase has a shallow pocket for the glutaryl chain. 
Comparing the substrate-binding residues of PvdQ and PsSY77 GL7-ACA acylase 
indicated that those of the PsSY77 GL7-ACA acylase are closer to 3-
oxododecanoic acid compared to those of PvdQ except for Leu222 and Gln248 
(Appendix Table 2). This suggests that smaller amino acids may accommodate 
AHLs with long acyl chains. 
Since PvdQ was the only structure of an AHL acylase at the time, amino acid 
sequences of other known AHL acylases (Appendix Table 3) were aligned against 
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the PsSY77 GL7-ACA acylase using Clustal Omega (Sievers et al., 2011) to 
determine whether AHL-binding residues were of a specific type (Appendix Table 
4). However, no trends regarding the AHL-binding residues were observed.  
Based on observations of the acylase structures, I chose to perform site-saturation 
mutagenesis on residues Met174, Tyr178, Leu222, Gln248, Arg255, Met347 and 
Phe375 of the PsSY77 GL7-ACA acylase. All these residues were previously 
identified to bind GL7-ACA (Kim et al., 2000) and have been previously mutated 
for new activities. 
3.2.3 Construction	of	AHL	acylase	site-saturation	mutagenesis	libraries	
Site-saturation mutagenesis was used to mutate the selected PsSY77 GL7-ACA 
acylase residues. NNK site-saturation mutagenesis (Reetz and Carballeira, 2007) 
was used to construct the Leu222X, Gln248X, Arg255X and Phe375X libraries. 
Each library consisted of a 96-well plate with 91 variants, four controls and a HSL 
or 7-ACA standard. Library statistics were calculated using GLUE (Patrick et al., 
2003). For NNK mutagenesis, 95% coverage for one mutated position requires 96 
variants with the expected completeness of a 91-variant library of 94%. For the 22c 
method (Kille et al., 2012), however, only 66 variants are needed for 95% coverage 
and the expected completeness of a 91-variant library is 98%. Therefore, the 22c 
method was used subsequently to construct the Met174X, Tyr178X and Met347X 
libraries as it improves the sequence coverage for the mutated position.  
All the libraries were constructed from the pET20b expression plasmid carrying 
PsSY77 GL7-ACA acylase, without a signal sequence and with a C-terminal His6 
tag for purification (Figure 2.5B). Overlap extension PCR was used to construct 
libraries for both mutagenesis strategies (Heckman and Pease, 2007) as described in 




Figure 3.3 Site-saturation mutagenesis using overlap extension PCR. 
The two fragments of the PsSY77 GL7-ACA acylase gene were amplified with the 
appropriate primer pairs (step 1). For NNK mutagenesis, each mix of forward and 
reverse degenerate primers encodes all 20 amino acids. The 22c method requires 
six mixes of primers, two degenerate ones and one encoding TGG or ACC to 
encode the 20 amino acids. These were mixed so that the ratios for 
NDT:VHG:TGG and NHA:BDC:ACC are 12:9:1 to ensure correct amino acid 
distribution in a library. DpnI was added to the amplified gene fragments to 
remove wild-type template and the fragments were then cleaned up with a kit (step 
2). These fragments were then joined together by PCR amplification to form whole 
genes that contain the desired mutations (step 3). 
The variant genes and the pET20b expression plasmid into which they were to be 
inserted were then digested with two restriction enzymes to produce 
complementary sticky ends and ligated to form the variant plasmids. E. coli 
BL21(DE3) cells were transformed with these variant plasmids and plated on agar 
to grow colonies. 
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The libraries constructed using the 22c method were checked using Quick Quality 
Control to ensure correct DNA diversity (Acevedo-Rocha et al., 2015) (Figure 3.4, 
Figure 3.5). Colonies grown on agar were resuspended in water, plasmid DNA 
was extracted and sent for sequencing (step 1-3). 
  
 
1. Scrape library colonies  
into water 





4. Correct for background 5. Plot library DNA diversity 
Figure 3.4 Quick Quality Control. 
Quick Quality control is carried out by calculating the percentage areas under the 
peaks for each base of the three codons for a given amino acid residue. The 
percentage area for each base is proportional to the relative concentration of the 
base (Carr et al., 2009). Background signals must be subtracted for each base (step 
4). This value is then divided by the total value of all bases at the given position to 
plot the DNA diversity of the library (step 5). 
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Figure 3.5 DNA diversity of 22c site-saturation mutagenesis libraries. Letters 
above pie charts represent bases of the wild-type codon. 
All libraries were also assessed for wild-type background and ambiguous sequences 
by random sequencing of ten variants as a representative sample unless stated 
otherwise (Table 3.2). Library assessment in these terms is important because a 
site-saturation library with a distribution biased toward the wild type or ambiguous 
variants would not be useful. 
Table 3.2 Assessment of site-saturation mutagenesis libraries. 
# from full library sequencing. 
Library Wild type Ambiguous  
Met174X  2 0 
Tyr178X#  5 0 
Leu222X 1 2 
Gln248X 0 2 
Arg255X# 6 0 
Met347X  2 1 
Phe375X 0 1 
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Based on Figure 3.5 and Table 3.2, the site-saturation mutagenesis libraries were 
deemed fit for further characterisation. Freezer stocks of these libraries were made 
and used to grow overnight cultures for protein over-expression. 
3.2.4 High-throughput	expression,	purification	and	screens	of	AHL	acylase	libraries	
Each library was expressed, purified and screened in triplicate as described in 
Section 6.5.2. The libraries were screened against six AHLs. These were grouped 
into pairs (C4- and C6-HSL, C8- and C10-HSL, C12- and 3-oxo-C12-HSL 
respectively) for three AHL screen plates. One screen was with DMSO, the solvent 
for AHLs, to account for background signals from eluted proteins. One screen was 
for GL7-ACA so native and new activities can be compared. Appendix Figure 2 
shows the range of variation in the controls from each library screen and their 
respective replicates. AHL acylase activity was not detected from the wild-type 
negative control. This is important as engineering new activities into a scaffold 
with no prior activity can generate weakly active variants (Section 2.1). 
Two criteria were used to determine if a library variant was worth exploring 
further. First, at least two of three replicates must be higher than the wild-type 
control to account for a variant that may not have been expressed or purified. 
Second, signals from AHL screens must be higher than the highest background 
signal from the corresponding DMSO screen. There is variation in background 
signal from the DMSO screen due to the varying amounts of protein eluted during 
purification (Appendix Figure 3). Based on these criteria, three new AHL acylase 
variants were discovered in the Arg255X site-saturation mutagenesis library from 
the C8- and C10-HSL, and C12- and 3-oxo-C12-HSL screens, respectively (Figure 
3.6). No AHL acylase variants were discovered in the other six libraries (Figure 
3.7 – 3.12). 
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Figure 3.6 Screening results from the Arg255X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 
Arg255Ala in orange, Arg255Gly in pink, Arg255Thr in yellow. Dotted line 
indicates cut-off point for activity. RFU represents relative fluorescence units. 
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Figure 3.7 Screening results from the Met174X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 




Figure 3.8 Screening results from the Tyr178X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 





Figure 3.9 Screening results from the Leu222X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 





Figure 3.10 Screening results from the Gln248X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 





Figure 3.11 Screening results from the Met347X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 





Figure 3.12 Screening results from the Phe375X site-saturation mutagenesis 
library. (A) C4- and C6-HSL. (B) C8- and C10-HSL. (C) C12- and 3-oxo-C12-HSL. 
(D) GL7-ACA. Controls and variants arranged in ascending order of activity from 
left to right, all three replicates shown. 40 nmol HSL standard in red, AHL 
acylase positive control in blue, vector-only control in light green, wild-type 
negative control in dark green, variants with no detectable activity in black. 
Dotted line indicates cut-off point for activity. RFU represents relative 
fluorescence units. 
Arg255Ala appears seven times, Arg255Gly five times and Arg255Thr eight times 
in the Arg255X library. The redundancy of these variants helped to determine that 




Figure 3.13 Fluorescence values from pooled variants in AHL acylase screens 
of Arg255X library. (A) C12- and 3-oxo-C12-HSL. (B) C8- and C10-HSL. n is the 
number of times the variant appears in the library. RFU represents relative 
fluorescence units. 
Arg255Gly shows AHL acylase activity in the C8- and C10-HSL screen as well as 
the C12- and 3-oxo-C12-HSL screens compared to the wild type. Arg255Ala shows 
more AHL acylase activity in the C8- and C10-HSL screen than in the C12- and 3-
oxo-C12-HSL screen. Arg255Thr does not show activity in the C12- and 3-oxo-
C12-HSL screen but has a large spread of values in the C8- and C10-HSL screen. 
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The native GL7-ACA acylase activities of the library variants were also explored. 
All the libraries showed similar trends in GL7-ACA acylase activity in the variants 
with the exception of Arg255X (Figure 3.6 – 3.12). To compare these trends, 






Figure 3.14 Comparison of GL7-ACA acylase activity. (A) Tyr178X variants. (B) 
Arg255X variants. GL7-ACA acylase activity shown in increasing order. Dark 
green represents wild type. n represents the number of times a variant 
appeared in the library. RFU represents relative fluorescence units. 
Many of the Tyr178X variants with low or no activity contained mismatches in 
their sequences and were not included in the analysis of GL7-ACA acylase activity. 
Of the 14 variants that did not appear to contain mismatches, none have a 
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significant effect on GL7-ACA acylase activity, with the exception of Glu178 
(Figure 3.15). All variants that showed GL7-ACA activity in the Arg255X library 
were wild type (Figure 3.15). This excludes asparagine, lysine and valine variants, 
which did not appear in the Arg255X library that was constructed.  
The discovery of three new AHL acylases with mutations at position 255 (Figure 
3.13) and the reduction of GL7-ACA acylase when arginine is replaced with other 
amino acids at position 255 (Figure 3.14) indicates that Arg255 has an important 
role in processing and/or catalysis of the GL7-ACA acylase. 
3.3 Discussion	
3.3.1 Choosing	PsSY77	GL7-ACA	acylase	residues	for	mutagenesis	
A structure-based approach was used to determine PsSY77 GL7-ACA acylase 
residues to mutate. Several structures exist for PvdQ and PsSY77 GL7-ACA 
acylase, including mutants. Thus, information is available with regard to the 
activity of these acylases as well as the processing that needs to occur beforehand. 
The full-length AHL acylase amino acid sequences showed a range of sequence 
identities from 17 (Aac versus AiiC) to 67% (PsyrHacB versus PaHacB), indicating 
that most of the acylase sequence does not affect acylase activity. Comparison of 
substrate-binding residues also did not indicate similarities (Appendix Table 4). It 
is known that N-terminal hydrolases have broad substrate specificity (Oinonen and 
Rouvinen, 2000) and that binding of the substrate leads to rearrangement of the 
side-chains of the pocket rather than rearrangement of the main chain (Kim et al., 
2000; Bokhove et al., 2010). This suggests that the active site of an acylase can 
accommodate different substrates, accounting for their promiscuity (Khersonsky 
and Tawfik, 2010). 
In terms of mutagenesis, the focus of past engineering work on the PsSY77 GL7-
ACA acylase has been on the area of the active site where the glutaryl group binds, 
for activity towards substrates that are like GL7-ACA (Table 1.1). Compared to 
GL7-ACA and substrates similar to it, AHLs have very different chemical groups 
(Figure 1.3A, Table 1.1). The fatty acyl groups of AHLs, which bind in the same 
area of the active site as the glutaryl group, are hydrophobic and can vary 
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considerably in length. The HSL group of AHLs is also smaller than the 7-ACA 
group of GL7-ACA. There are PsSY77 GL7-ACA acylase residues that interact 
with 7-ACA (Tyr178, Ser181, Arg184, Leu222 and Val268). However, they are not 
thought to be important in recognising GL7-ACA (Kim and Kim, 2001; Kim and 
Hol, 2001). Residues that interact with HSL are currently unknown because no 
AHL acylase structures have been solved with an intact AHL (Bokhove et al., 2010; 
Koch et al., 2014b; Yasutake et al., 2017). 
Saturation mutagenesis was a good technique to choose for this project compared 
to a solely rational or random technique because substrate-binding residues of 
AHL acylases are not predictable (Appendix Table 4) and because the substrates 
for which I engineered the PsSY77 GL7-ACA acylase have different structures to 
previous substrates for which engineering was carried out (Figure 1.3A, Table 
1.1).  
3.3.2 Construction	of	AHL	acylase	site-saturation	mutagenesis	libraries	
Many factors affect the amino acid distribution of enzyme variant libraries. This 
includes the form of site-saturation mutagenesis used to construct the library e.g. 
NNK and 22c, and the steps taken during the library construction. 
The 22c site-saturation method is an improvement on NNK mutagenesis, reducing 
the number of variants needed to achieve high coverage, lowering codon bias and 
not allowing stop codons (Table 3.1). However, there still can be issues with this 
form of mutagenesis.  
During the PCR to carry out 22c mutagenesis, different annealing temperatures can 
produce codon bias that can skew the amino acid distribution of a library (Kille et 
al., 2012). Overlap extension PCR was used to try and minimise this bias (Figure 
3.3). In step 1 of overlap extension PCR, the two parts of the PsSY77 GL7-ACA 
acylase gene were amplified using different annealing temperatures. This appeared 
to have an effect on the first codon position of the three 22c libraries but not on the 
second or third (Figure 3.5). 
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Other issues include the presence of wild-type codons in the primers for creating 
the 22c libraries or incomplete digestion of the wild-type template before step 2 of 
overlap extension PCR (Figure 3.3). Sequencing of all the Arg255X and Tyr178X 
variants showed that 5 to 6 wild types can be present in a library of 91 variants, 
which at 6% is low enough to proceed with (Table 3.2). Another issue that can 
occur is the appearance of overlapping variant sequences. This can occur if a 
colony contains more than one plasmid, due to transformation of too much DNA 
into cells or if overlapping colonies are picked into the same well. Library 
assessment (Figure 3.5, Table 3.2) is important for such enzyme engineering 
projects to ensure that a library is diverse enough with as few non-functional 
variants as possible so that the likelihood of discovering a desired variant is 
increased. 
3.3.3 High-throughput	expression,	purification	and	screens	of	AHL	acylase	libraries	
Several things affected the ability to identify AHL acylase variants from the 
screens. Sometimes, variants did not grow overnight because they were not picked 
properly from the freezer stock and therefore could not be expressed and purified. 
If the variants grew and proteins were expressed and purified, the way the library 
was constructed can affect the ability to identify AHL acylase variants as well. If 
mutations were introduced during PCR amplification, this can result in truncated, 
insoluble or unfolded proteins. The Tyr178X library demonstrates this as many of 
the variants with low or no activity against GL7-ACA acylase contained base 
mismatches, which would change the amino acid sequence of the subsequent 
protein (Figure 3.8). The Tyr178X, Met174X and Met347X libraries were 
constructed using DNA polymerase from Thermus aquaticus. This DNA polymerase 
has a higher error rate than the Phusion Pyrococcus-like DNA polymerase, which 
was used to construct other libraries. Many of the Tyr178X variants contained 
mismatches in the nucleotide sequence aside from the position being mutated. The 
14 variants in the Tyr178X library included in the GL7-ACA activity analysis do 
not have mismatches in the region surrounding the mutated position but may have 
them elsewhere in the gene. None of the 14 Tyr178X variants appeared to decrease 
GL7-ACA activity significantly except Glu178 (Figure 3.14). 
 78 
From triplicate screening of 637 variants against six AHLs, I found new AHL 
acylase variants active against long-chain AHLs, Arg255Ala, Arg255Gly and 
Arg255Thr. These AHL acylase screens demonstrate that enzymes with new 
activities can be engineered from a template that does not have prior activity 
towards the target substrates. While these new enzymes have low activity, the 
screens were sensitive and robust enough to detect them. Only the Arg255Ala and 
Gly variants were further characterised as described in Chapter 4. The role of 
































The last aim of this project was to further characterise the AHL acylase variants 
identified by high-throughput screening. These variants were tested for their ability 
to degrade specific AHL substrates and for their ability to disrupt biofilm 
formation. 
As mentioned in Section 1.1.1, bacteria behave differently when they live as a 
biofilm compared to when they are planktonic (Flemming and Wingender, 2010). 
Therefore, different methods are required to study them in their different states. 
Biofilms can be grown and analysed using several methods (Peterson et al., 2011; 
Azeredo et al., 2017). Each fulfils different experimental requirements and has its 
advantages and disadvantages.  
For this project, the Calgary Biofilm Device (Harrison et al., 2010) was used to 
assay for quorum quenching against biofilms. Cultures are grown in the wells of a 
96-well plate and biofilms form on the surface of the lid pegs. This device allows 
high-throughput screening of biofilms and side-by-side replication of experiments, 
which cannot be done with continuous growth methods. It also allows several 
methods of analysing the biofilms grown on the pegs including crystal violet 
staining (O'Toole, 2011) and scanning electron microscopy (Harrison et al., 2006). 
Crystal violet staining is commonly used for quantifying total biofilm mass while 
scanning electron microscopy can be performed because the pegs can be removed 
from the lid and allows observation of biofilm structure (Azeredo et al., 2017). This 
allows correlation between quantitative and qualitative data. 
Both quorum-quenching enzymes, AHL lactonases and acylases (Section 1.3.2), 
have been shown to have in vivo activity against quorum-sensing bacteria as 
biofilms and in host infection models when administered externally as purified 
proteins. Using crystal violet assays and confocal microscopy, Chow et al. (2014) 
showed that the amount of biofilm formed by Acinetobacter baumannii was reduced 
in the presence of an improved variant of the Geobacillus kaustophilus AHL 
lactonase. Guendouze et al. (2017) also showed that an engineered variant of the S. 
solfataricus lactonase reduced biofilm mass in several clinical isolates of P. aeruginosa 
PAO1.  
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More evidence of quorum quenching activity is present in the literature for host 
infection models. Addition of purified PvdQ increases the life span of 
Caenorhabditis elegans grown in the presence of P. aeruginosa PAO1 (Papaioannou et 
al., 2009). The lactonase MomL also increases the life span of C. elegans when it 
was infected with P. aeruginosa PAO1 (Tang et al., 2015). However, this enzyme 
was lyophilised before administration. Larvae of the great wax moth survived 
infection by the bacteria B. cenocepacia after they were injected with the bacteria that 
were previously incubated with the Leu169Trp/Phe240Tyr variant of PvdQ that 
degrades C8-HSL (Koch et al., 2014b). The most recent demonstration of in vivo 
AHL acylase activity was with PfmA, which increased the survival rate of brine 
shrimp infected with P. aeruginosa PAO1 (Liu et al., 2017).  
These experiments demonstrate the potential for quorum-quenching enzymes to be 
used against bacterial infections. 
This chapter describes the in vitro characterisation of AHL acylase variants 
engineered in Section 3.2.4, and testing for quorum-quenching activity against P. 
aeruginosa PAO1 biofilms. 
4.2 Results	
4.2.1 Expression	and	purification	of	new	acyl-homoserine	lactone	acylases	
Three AHL acylases were discovered from the Arg255X library (Arg255Ala, 
Arg255Gly and Arg255Thr). The Arg255Ala and Arg255Gly variants were carried 
forward for characterisation but not the Arg255Thr variant, as its activity was not 
as clearly distinguishable from the wild type  (Figure 3.13). The Arg255Ala and 
Arg255Gly variants were expressed and purified as described in Sections 6.4.1 and 
6.4.3. Both variants purified as a mix of species: a small amount of full-length 
unprocessed enzyme, the predominant primary-processed enzyme with a β subunit 
and an α subunit with the spacer attached, and a small amount of the fully-
processed enzyme. Degradation products from the variants were also observed and 
confirmed by mass spectrometry as for the wild type. 
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Figure 4.1 Representative SDS-PAGE gel of PsSY77 –ss GL7-ACA acylase His6 
Arg255Ala and Arg255Gly purification. Lanes are pre-induction, post-induction, 
total protein, soluble protein, unbound fraction, washes 1-3, protein ladder, 
elution fractions 1-3. Black arrow indicates unprocessed enzyme, blue arrow β 
subunit, red arrow α subunit with spacer attached. Box highlights degradation 
products. 
4.2.2 Activity	assays	of	the	new	acyl-homoserine	lactone	acylases	
The high-throughput screens were carried out against pooled pairs of AHLs 
(Section 3.2.4). Therefore, the activity of the Arg255Ala and Arg255Gly variants 
was tested against C8-, C10-, C12- and 3-oxo-C12-HSL individually as described in 
Section 6.4.9.2. The Arg255Ala and Arg255Gly variants gained activity against 
C10-, C12- and 3-oxo-C12-HSL (Figure 4.2). Activity appeared to decrease with 
increasing length of the acyl chain and addition of the oxo-group. Interestingly, 
activity against GL7-ACA was completely abolished. 
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Figure 4.2 Acylase activities of Arg255X variants against different substrates. 
RFU represents relative fluorescence units. 
Specific enzyme activity was determined for the Arg255Ala and Arg255Gly 
variants. This was done because the purified variants contained degradation 
products (Figure 4.1). Specific enzyme activity accounts for the total amount of 
protein present in an assay (Bisswanger, 2014). First, standard curves of HSL were 
determined to calibrate the amount of product to quantify specific enzyme activity 
(Figure 4.3). A final concentration of 100 nM purified protein, which is the 
concentration of protein used to determine specific enzyme activity, was added to 
the standard curve, to account for background signal from protein. 
 84 
 
Figure 4.3 HSL standard curve with and without 100 nM protein. RFU represents 
relative fluorescence units. 
Assays were optimised such that the period of enzyme activity is linear while also 
producing a detectable fluorescent signal (Appendix Figure 4, Appendix Figure 5) 
and specific enzyme activity was then calculated (Section 6.4.9.2). 
The Arg255Gly variant has roughly the same amount of activity against C10- and 
C12-HSL but activity against 3-oxo-C12-HSL is one hundred times lower (Table 
4.1).  
Table 4.1 Specific enzyme activity against substrates in µmol HSL min-1 mg-1. 
Substrate Arg255Ala Arg255Gly 
C10-HSL (1.1 ± 0.3) x 10-5 (1.8 ± 0.2) x 10-5 
C12-HSL n.d. (2.6 ± 0.3) x 10-5 
3-oxo-C12-HSL n.d. (9.4 ± 0.8) x 10-7 
 
 
The specific activity of the Arg255Ala variant against C12-HSL was not detectable 
over the period measured while activity against 3-oxo-C12-HSL was too low over 
the period measured to calculate specific enzyme activity (Appendix Figure 5). 
The Arg255Gly variant was carried forward for further characterisation, as it was 





To investigate the stability of the Arg255Gly variant, a buffer screen was carried 
out as described in Section 6.4.8 (Figure 4.4). 
 
Figure 4.4 PsSY77 GL7-ACA acylase Arg255Gly buffer screen. Final storage 
buffer used highlighted in blue. 
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The Arg255Gly variant has a melting temperature of ~56 ˚C in the storage buffer 
while the wild-type enzyme has a melting temperature of ~55 ˚C (Figure 2.8). This 
is consistent with observations from Cho et al. (2009), where variants with impaired 
processing unfolded at higher concentrations of urea compared to the wild-type 
enzyme.  
The Arg255Gly variant was further purified by size exclusion chromatography to 






Figure 4.5 Determination of PsSY77 GL7-ACA acylase Arg255Gly quaternary 
conformation. (A) Size exclusion chromatography trace for PsSY77 GL7-ACA 
acylase Arg255Gly. Blue bar indicates fractions used for SDS-PAGE. (B) SDS-
PAGE of elution fractions, blue arrow β subunit, red arrow α subunit with spacer 
attached. (C) Size exclusion chromatography trace for calibration standards. A, 
gamma globulin 158 kDa; B, ovalbumin, 44 kDa; C, myoglobin, 17 kDa; D, 
vitamin B12, 1.3 kDa. (D) Calibration curve. 
The Arg255Gly variant eluted at a similar volume as the wild-type enzyme (Figure 
4.5, Figure 2.9), indicating that the glycine mutation does not change the 
quaternary structure of the acylase. The Arg255Gly variant remained partially 
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processed after size exclusion chromatography, consistent with other Arg255 
variants (Kim et al., 1999; Cho et al., 2009). Degradation products from the enzyme 
were also not removed. 
4.2.4 Crystallography	trials	of	the	Arg255Gly	variant	
To explore the effect of the glycine mutation, I attempted to solve the structure of 
this variant. Seven 96-well commercial screens were used for initial trials (Section 
6.4.10). At 4 mg/mL protein, well A10 of the University of Auckland Robot 
Screen I (0.2 M sodium chloride, 20% PEG 3350, pH 6.9) showed conditions 
possible for crystallisation (Figure 4.6). This is consistent with the conditions used 
for crystallising other PsSY77 GL7-ACA acylase variants (Kim et al., 2006; Cho et 
al., 2009). However, at 30 mg/mL protein, which is the concentration of the 
PsSY77 GL7-ACA acylase used for crystallisation from the literature, the 
Arg255Gly variant precipitates under all conditions (Figure 4.6). 
 
Figure 4.6 Commercial screens of PsSY77 GL7-ACA acylase Arg255Gly. (A) 4 
mg/mL protein in 0.2 M sodium chloride, 20% PEG 3350, pH 6.9. (B) 
Representative well of 30 mg/mL protein precipitation. 
 
Based on the possible crystallisation condition found, and conditions from Cho et 
al. (2009) and Kim et al. (2006), a fine screen was optimised and carried out against 
the Arg255Gly variant (Section 6.4.10). However, no crystals were derived from 
this screen. This is perhaps unsurprising as Kim et al. (2006) showed that the 
Arg255Lys variant could be crystallised when it only undergoes primary 
 88 
processing. After 12 days, the Arg255Lys variant undergoes some secondary 
processing but this form cannot be crystallised (Kim et al., 2006). This result 
suggests that a similar issue occurs with the Arg255Gly variant, which also 
undergoes some secondary processing. 
4.2.5 Computational	modelling	of	the	Arg255Gly	variant	
Since no crystals were derived from crystallography trials of the Arg255Gly 
variant, computational modelling was used to understand the catalytic activity of 







Figure 4.7 Comparing acylase active sites containing 3-oxo-C12-HSL. (A) 
PsSY77 GL7-ACA acylase Arg255Gly in grey sticks. (B) PvdQ in green sticks. (C) 
PsSY77 GL7-ACA acylase in teal sticks. 3-oxo-C12-HSL in yellow sticks. 
C10-, C12- and 3-oxo-C12-HSL were modelled into the Arg255Gly variant using 
the Genetic Optimisation for Ligand Docking (GOLD) program (Jones et al., 1997) 
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as described in Section 6.4.11 (Figure 4.7A, Appendix Figure 6). To compare 
how 3-oxo-C12-HSL sits in the active sites of the different acylases, this was also 
modelled into the AHL acylase PvdQ (PDB 2WYC) and the PsSY77 GL7-ACA 
acylase (PDB 1OR0) using PyMol (Version 1.8, Schrödinger, LLC) (Figure 4.7). 
All three AHLs docked in a similar position to each other in the Arg255Gly model, 
with the amide bond in close proximity to the catalytic serine (Figure 4.7A, 
Appendix Figure 6). In each acylase, the orientation of Gly255, Asn273 and 
Arg255 is different (Figure 4.7). Gly255 has a small side-chain, Asn273 points 
away from the active site while Arg255 points into the active site. A change from 
arginine to glycine at position 255 of the PsSY77 GL7-ACA acylase caused the 
enzyme to lose activity against GL7-ACA and gain activity against these three 
AHLs (Figure 4.2). 
As no crystals were derived for the Arg255Gly variant, the structure of an 
Arg255Lys variant was used to understand this change in activity. Kim et al. (2006) 
solved the structure of this Arg255Lys variant (PDB 2AE3) in a state where it had 
only undergone the first step of autocatalytic processing and the spacer was still 
present in the structure. It is also known that the Arg255Lys variant has a small 
amount of acylase activity against GL7-ACA, with a kcat/Km of 0.03 mM-1 s-1, as 
opposed to 12.34 mM-1 s-1 for the wild-type enzyme (Cho et al., 2009). There are 
three possible scenarios to explain the low GL7-ACA acylase activity of the 
Arg255Lys variant: Both fully- and partially-processed enzymes are active against 
GL7-ACA, only the small amount of fully processed enzyme is active, or the large 








Figure 4.8 The effect of mutation at position 255 on acylase processing. (A) 
PsSY77 GL7-ACA acylase Arg255Lys in blue sticks with primary-processed 
spacer in beige sticks and GL7-ACA in pink sticks. (B) PsSY77 GL7-ACA acylase 
in teal sticks with GL7-ACA in pink sticks. 
The structures of the PsSY77 GL7-ACA acylase (PDB 1OR0) and the Arg255Lys 
variant (PDB 2AE3) were compared using PyMol (Version 1.8, Schrödinger, LLC) 
(Figure 4.8). The spacer attached to the αsubunit of the Arg255Lys variant does 
not occupy the active site (Kim et al., 2006), suggesting that it does not block entry 
of GL7-ACA into the active site. Therefore, the residue at position 255 likely 
affects acylase activity because the activity of the Arg255Lys variant against GL7-
ACA is reduced considerably. Therefore, the Arg255Gly variant lost GL7-ACA 





Since 3-oxo-C12-HSL is a quorum-sensing signal of P. aeruginosa PAO1, the 
Arg255Gly variant was tested for quorum-quenching activity P. aeruginosa biofilms 
using the Calgary Biofilm Device as described in Section 6.6.2. Two isolates were 
tested: a laboratory strain and a clinical isolate (Table 6.1). 
Based on the crystal violet assay, there was no significant difference between the 
biofilms treated with the Arg255Gly variant compared to untreated biofilms of 





Figure 4.9 Crystal violet assay to determine activity of the Arg255Gly variant 
against P. aeruginosa biofilms. (A) Laboratory strain. (B) Clinical isolate. 
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Pegs of the Calgary Biofilm Device with biofilms growing on them were also 
processed for scanning electron microscopy as described in Section 6.6.4. From 
qualitative observation of scanning electron microscopy images (Figure 4.10, 
Appendix Figure 7, Figure 4.11, Appendix Figure 8), the Arg255Gly variant 








Figure 4.10 Representative scanning electron microscopy images of P. 
aeruginosa biofilms from the laboratory strain. (A) Untreated. (B) Treated with 
GL7-ACA acylase. (C) Treated with GL7-ACA acylase Arg255Gly variant. Images 









Figure 4.11 Representative scanning electron microscopy images of P. 
aeruginosa biofilms from a clinical isolate. (A) Untreated. (B) Treated with GL7-
ACA acylase. (C) Treated with GL7-ACA acylase Arg255Gly variant. Images 




Of the seven positions screened, the only active variants observed contained 
mutations at position 255. The best was the Arg255Gly variant. Mutation from 
arginine to glycine is a drastic change: glycine is much smaller and more 
hydrophobic than the positively charged arginine. The glycine mutation changed 
the activity of the PsSY77 GL7-ACA acylase. Native activity against GL7-ACA 
was lost while activity against long-chain AHLs was gained (Table 4.1, Appendix 
Figure 4).  
Mutations at position 255 also impaired autocatalytic processing of the PsSY77 
GL7-ACA acylase as described in Section 1.4. The Arg255Gly variant undergoes 
the first step of autocatalytic processing completely but only undergoes the second 
step partially (Figure 4.4). This impairment of processing has also been observed 
by Kim et al. (2006). A change from arginine to lysine at position 255 reduced 
processing such that it took the Arg255Lys variant 12 days to become fully 
processed and reduces the native activity of the PsSY77 GL7-ACA acylase from a 
a kcat/Km of 12.34 mM-1 s-1 to 0.03 mM-1 s-1 (Cho et al., 2009).  
The first step of autocatalytic processing uses the nucleophile of the first residue of 
the β subunit to hydrolyse the peptide bond between this residue and the last 
residue of the spacer (Section 1.4). This first step of autocatalytic processing causes 
a change in the conformation of the spacer, allowing the second step to proceed 
(Cho et al., 2009). However, mutations in the enzyme can prevent one or both steps 
of this processing by changing the interactions between the active site residues to 
allow processing and by changing the conformation of the spacer. Lysine at 
position 255 allows the second step of autocatalytic processing to proceed slowly 
(Cho et al., 2009). However, serine and isoleucine at position 255 prevents the 
second step of processing and abolishes GL7-ACA acylase activity completely (Oh 
et al., 2003; Yoon et al., 2004). The same was observed for glycine at position 255. 
Arginine has two amino groups on its side-chain while lysine only has one amino 
group on its side chain so this is not as drastic as a change to glycine. My results 
plus these observations indicate that the properties of the residue at position 255 is 
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important in determining the enzyme’s ability to process itself and carry out 
catalysis. 
The Arg255Gly variant has similar levels of specific activity against C10- and C12-
HSL but 100-fold less activity against 3-oxo-C12-HSL (Table 4.1). This suggests 
that the difference in length between C10- and C12-HSL does not affect the activity 
of the Arg255Gly variant against either AHL. Since activity of the Arg255Gly 
variant is much lower against 3-oxo-C12-HSL, the oxygen atom may play a role in 
impairing the acylase activity (Figure 4.7).  
The Arg255Gly variant was tested against P. aeruginosa biofilms to see whether this 
weak activity against 3-oxo-C12-HSL has an effect on biofilm formation. P. 
aeruginosa biofilms from a laboratory strain and a clinical isolate were grown for a 
total of 48 hours with the Arg255Gly variant added at the beginning of growth and 
again at 24 hours (Section 6.6.2). The Arg255Gly variant appeared to reduce 
production of the extracellular matrix relative to biofilms grown in the presence of 
the wild-type PsSY77 GL7-ACA acylase (Figure 4.10, Appendix Figure 7, Figure 
4.11, Appendix Figure 8). The P. aeruginosa LasI/R system, which uses 3-oxo-C12-
HSL, influences the pel operon that produces a polysaccharide for formation of the 
biofilm matrix (Sakuragi and Kolter, 2007). Transcription of pelA was reduced in 
lasI and lasR mutants of P. aeruginosa compared to the wild-type strain. These 
mutants also showed different colony morphologies to the wild-type strain. 
Complementation of the lasI mutant with 3-oxo-C12-HSL restored transcription of 
pelA and colony morphology to that of the wild-type strain. In terms of this project, 
this suggests that the Arg255Gly variant is able to degrade 3-oxo-C12-HSL present 
in P. aeruginosa biofilms. In doing so, the amount of polysaccharide of the biofilm 
matrix for the P. aeruginosa strain used in the laboratory as well as an isolate from 
an infected implant is reduced. 
Of the three AHL acylase variants engineered and detected in the library screen, 
the Arg255Ala and Arg255Gly variants were purified and characterised for 
activity. The Arg255Gly variant may have quorum quenching activity against P. 
























The overall aim of this project was to understand how AHL acylases work so that 
they can be engineered as quorum-quenching enzymes against P. aeruginosa PAO1 
biofilm infections. 
This project has shown that the PsSY77 GL7-ACA acylase can be engineered for 
substrates with long acyl chains. Previous engineering work of the PsSY77 GL7-
ACA acylase has been for substrates with small differences in the acyl chain 
compared to GL7-ACA (Otten et al., 2002; Sio et al., 2002; Oh et al., 2003) (Table 
1.1). More recently, Isogai and Nakayama (2016) engineered variants that break 
down echinocandin, a cyclic lipopeptide with a long acyl chain. In this project, two 
acylases (Arg255Ala and Arg255Gly) active against AHLs with long acyl chains 
(C10-, C12- and 3-oxo-C12-HSL) were engineered and detected from screening of 
637 variants against six AHLs (Figure 3.7, Figure 3.13). This engineering was 
possible with the availability of structures of the PsSY77 GL7-ACA acylase and the 
AHL acylase PvdQ as well as the development of a sensitive high-throughput 
screen to identify AHL acylases (Section 2.2.4). Variants in this project were 
created from a scaffold with no prior activity for the desired substrates (Appendix 
Figure 1), a challenge for enzyme engineering. A screen using biosensors would 
not have been sensitive enough to detect these variants. The fluorescence screen 
developed here can be used to find other AHL acylases and with specific 
optimisation, can be used to discover or engineer other enzymes that produce 
primary amines from other substrates. 
This project aimed to use iterative saturation mutagenesis to incrementally improve 
AHL acylase activity of variants (Figure 3.1). However, only one position of the 
seven chosen for site-saturation mutagenesis produced new AHL acylase variants. 
Other positions in the PsSY77 GL7-ACA acylase should be considered to discover 
more variants to carry out the next step of iterative saturation mutagenesis. Other 
mutagenesis strategies could also be explored such as error-prone PCR of specific 
regions of the active site (Otten et al., 2002; Sio et al., 2002). However, this will 
require more high-throughput methods to identify AHL acylases to deal with the 
increased number of variants. All currently known AHL acylases can hydrolyse a 
broad range of AHLs and even certain antibiotics (Section 2.1). A penicillin 
acylase was also previously shown to hydrolyse AHLs as well (Mukherji et al., 
 99 
2014). This provides another avenue for developing new AHL acylases as the 
substrate-binding residues are diverse (Appendix Table 4) and a broad range of 
configurations appears to allow for such substrate promiscuity. The cross-reactivity 
against quorum-sensing signals and antibiotics may indicate an evolutionary 
connection in the physiological use of acylases (Avinash et al., 2014) or raises the 
issue of enzymatic nomenclature in relation to true physiological enzymatic 
activity (Utari et al., 2017). A way to investigate this would be to carry out ancestral 
reconstruction of AHL and antibiotic acylases. The TIM barrel AHL lactonases 
(Section 1.3.2.1) are thought to be the progenitors of phosphotriesterases, which 
degrade paraoxon, a pesticide introduced in the 20th century (Afriat et al., 2006). 
From the high-throughput screening, it was found that Arg255 is an important 
residue for autocatalytic processing and activity of the PsSY77 GL7-ACA acylase 
(Section 4.3). Any change to this residue abolishes GL7-ACA acylase activity 
(Figure 3.14). The AHL acylase variants engineered in this project lost GL7-ACA 
acylase activity but also could not carry out the second step of catalytic processing 
(Section 1.4). To determine whether the impaired processing has an effect on the 
activity of the new AHL acylases, these variants can be cloned using circular 
permutation. Normally, acylases are expressed as a polypeptide starting with the α 
subunit, followed by the spacer and β subunit. With circular permutation, the 
sequence is rearranged such that the acylase is expressed starting with the β subunit 
followed by a short linker then the α subunit. A circular-permuted acylase does not 
require processing to become enzymatically active. This has been previously done 
for PvdQ without any loss of acylase activity (Clevenger et al., 2017). Another 
avenue of research would be to investigate positions homologous to the PsSY77 
GL7-ACA acylase Arg255 in other AHL acylases to see the effect on processing 
and activity and to aid further engineering work. Molecular dynamics would also 
be useful to understand how autocatalytic processing occurs in real time as 
structures only provide a static view of a protein at a given moment. 
The Arg255Gly variant, which has weak in vitro activity against 3-oxo-C12-HSL, a 
P. aeruginosa PAO1 quorum-sensing signal did not reduce biofilm mass of P. 
aeruginosa biofilms, but reduced the amount of biofilm matrix present (Section 
4.2.6). As this was a variant on the first step of iterative saturation mutagenesis, it 
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requires improvement of its activity as mentioned previously. The Arg255Gly 
variant has the most activity against C10-HSL. Its activity against 3-oxo-decanoyl 
homoserine lactone would be worth characterising, as this is a quorum-sensing 
signal of Vibrio anguillarum, a pathogen that infects fish (Milton et al., 1997). The 
Shewanella sp. strain MIB015 Aac AHL acylase has been previously shown to 
reduce V. anguillarum biofilm formation (Morohoshi et al., 2008). 
Quorum-quenching enzymes have been demonstrated to have potential for use in 
both clinical and industrial applications. For clinical use, two approaches have 
been attempted, formulation for internal administration and coating of medical 
implant surfaces. Rats with pneumonia and P. aeruginosa infections treated 
immediately through the trachea with a solution of S. solfataricus AHL lactonase 
were shown to survive longer than untreated rats (Hraiech et al., 2014). As 
mentioned before in Section 1.3.2.2, PvdQ has also been formulated as a dry 
powder for administration to cystic fibrosis patients. While this is more stable than 
in liquid form, this has yet to be tested in vivo. Other AHL-degrading enzymes have 
been used to coat urinary catheters (Afriat et al., 2006; Ivanova et al., 2015a; 
Ivanova et al., 2015b). These were shown to reduce biofilm formation in vivo with 
rabbits and were not toxic to human skin cells. In terms of industry, quorum-
quenching enzymes have been immobilised for wastewater treatment. The AHL 
lactonase AiiA (Dong et al., 2000) was immobilised on magnetic particles so they 
can be recovered and reused (Beladiya et al., 2015) while another AHL-degrading 
enzyme immobilised on similar magnetic particles was shown to prevent the 
formation of mature P. aeruginosa PAO1 biofilms on water filtration membranes 
(Lee et al., 2014). Engineering of quorum-quenching enzymes has also been carried 
out to improve yield and expand susbtrate specificity (Chow et al., 2009; Chow et 
al., 2010; Hiblot et al., 2013; Koch et al., 2014b). Engineering and application of 
quorum-quenching enzymes in clinical and industrial contexts are possible and 
useful. 
While this is the case, resistance to quorum quenching has been reported (Section 
1.3.3). Quorum quenching relies on the premise that quorum sensing is not 
essential to bacterial growth and that bacteria will not develop resistance so quickly 
to it. However, a specific environment may cause a downstream product of 
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quorum sensing to be necessary for bacteria to grow (Maeda et al., 2012). Quorum 
sensing is complex and regulates the expression of up to 11% of the P. aeruginosa 
genome (de Kievit, 2009). Therefore, resistance to quorum quenching can be 
mediated in ways we are not able to predict as yet. Variation in quorum sensing 
among strains of P. aeruginosa is likely to cause the appearance of resistance to 
quorum quenching (Defoirdt et al., 2010). Biofilm formation, mediated by quorum 
sensing (O'Toole et al., 2000), also varies among strains within the same species 
(Head and Yu, 2004; Guendouze et al., 2017). Besides this, changes of environment 
over time also contribute to physiological variation within a biofilm (Figure 5.1). 
 
 
Figure 5.1 Factors contributing to biofilm formation and development. 
For example, populations within a biofilm community can exhibit different types 
of variation such as loss of the ability to produce quorum-sensing signals (Allen et 
al., 2014). This in turn means that the types of interactions between individuals 
within that community would also be different. Therefore, selection pressure to 
develop resistance to quorum quenching will depend on the environmental context, 
the population variation within species and the form of quorum quenching used. 
Quorum quenching can involve intracellular inhibition using small molecules that 
bind to quorum-sensing signal synthases or receptors or extracellular inhibition 
using enzymes that degrade the signals (Section 1.3). Small-molecule inhibition 
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may lead to increase in expression of synthases or receptors with mutations to 
compensate the loss of activity (Allen et al., 2014). Extracellular quorum quenching 
may be the better option as the enzyme does not need to be inside the cell to carry 
out inhibition and may not select for resistance the way small molecules might. 
Synergistic use of different forms of quorum quenching is worth exploring. 
Overall, this project is the first report of engineering of the PsSY77 GL7-ACA 
acylase for AHL acylase activity with potential for quorum-quenching to inhibit 
biofilm formation. Prior to this work, the only AHL acylase engineering has been 
for PvdQ, to switch its specificity. This project also shows that acylases with other 
activities can be engineered for activity against AHLs, broadening the scope for 



























Lysogeny Broth Miller (LB), Terrific Broth Phosphate Buffered (TB), Auto 
Induction Media Terrific Broth Base including trace elements (TB-AIM), tryptone 
and agar were from Formedium (Hunstanton, England). Yeast extract and PEG 
6000 were from Merck (Darmstadt, Germany). Agarose was from Hydragene 
(Xiamen, China). Glycerol, dipotassium hydrogen phosphate, potassium 
dihydrogen phosphate, sodium chloride, imidazole, BugBuster ® 10× Protein 
Extraction Reagent and Benzonase ® Nuclease 250 U/µL were from EMD 
Milllipore (Billerica, MA, USA). Fluorescamine, protease inhibitor cocktail, L-
homoserine-lactone hydrochloride, glutaric acid, 7-ACA, sodium cacodylate 
trihydrate, iron (III) chloride, PEG 3350, PEG 8000, L-arginine 
monohydrochloride and crystal violet were from Sigma Aldrich (St. Louis, MO, 
USA). Egg white lysozyme, IPTG, sodium ampicillin and disodium carbenicillin 
were from Gold Biotechnology (St. Louis, MO, USA). Disodium ethylenediamine 
tetraacetic acid dihydrate, potassium acetate, sodium acetate trihydrate, 
magnesium sulfate, magnesium chloride and glucose were from Scharlau 
(Sentmanat, Spain). Ammonium sulfate was from VWR (Radnor, PA, USA). 50% 
w/v PEG was from Molecular Dimensions (Maumee, OH, USA). KAPA 
Universal DNA Ladder (100 ng/µL) and DNA Loading Dye 6× were from KAPA 
Biosystems (Wilmington, MA, USA). Precision Plus ProteinTM All Blue Standards, 
ethidium bromide 10 mg/mL, ammonium persulfate, acrylamide/bis (40% 
solution, 29:1 acrylamine:bis-acrylamide) and tris solutions were from Bio-Rad 
(Hercules, CA, USA). TALON ® Metal Affinity Resin was from Clontech 
(Mountain View, CA, USA). Premixed tris base, acetic acid and EDTA (TAE) 
buffer 10× were from Roche Diagnostics (Mannheim, Germany). Kanamycin 
sulfate and tris hydrochloride were from Applichem (Darmstadt, Germany). 
SYPRO ® Orange protein gel stain was from Life Technologies (Eugene, OR, 
USA). SYBR® Safe DNA Gel Stain and acetic acid were from Thermo Fisher 
Scientific (Waltham, MA, USA). C4-HSL and C12-HSL were from Cayman 
Chemical (Ann Arbor, MI, USA). C6-HSL, C8-HSL, C10-HSL, 3-oxo-C12-HSL 




Table 6.1 Bacterial strains used. 
Strain Genotype Purpose Source/Reference 
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- Infected knee implant 
from patient in 
Christchurch hospital. 
Identified as P. 
aeruginosa by 16sRNA 
sequencing and as 
ST253 from clonal 
complex PA14 by 
multilocus sequence 
typing. Sequencing and 
typing was conducted by 
the Protein Science and 




For bacteria grown on agar plates, LB agar (25 g/L LB, 1.5% w/v agar) was 
prepared in water and sterilised. The LB agar was cooled to ~55 °C and the 
appropriate antibiotic added. Antibiotics were added to final concentrations as 
follows: 0.1 mg/mL for ampicillin and carbenicillin and 0.03 mg/mL for 
kanamycin. Petri dishes were filled with ~25 mL agar. Once dry, plates were stored 
at 4 °C. Cells were streaked out or spread on these plates and grown overnight at 
37 °C. 
Overnight cultures were grown from single colonies or freezer stocks in LB with 
antibiotics as needed and shaken at 37 °C. To make cell line freezer stocks, 
overnight cultures were mixed with sterile 50% glycerol w/v in a ratio of 7:3. For 
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single cultures, freezer stocks were made to 1 mL in 1.2 mL cryogenic vials. For 
site-saturation mutagenesis libraries, these were made to 200 µL in 96-well flat 
bottom transparent microplates. All freezer stocks were stored at -80 °C. 
6.2.3 Preparation	of	electrocompetent	cells	
Overnight cultures at a volume of 5 mL were used to inoculate 350 mL LB the next 
day. This was shaken at 37 °C until the optical density at 600 nm (OD600) was ~ 
0.35-0.40. The cells were chilled on ice for twenty minutes and washed with chilled 
sterile 10% glycerol w/v three times. Cells were harvested at 1000 g at 4 °C for 
fifteen minutes. These were concentrated to an OD600 of 100 and stored at -80 °C. 
6.2.4 Transformation	
Electrocompetent cells were thawed on ice and DNA (~1 µL plasmid or ligation) 
was added to a 0.2 mm Gene Pulser/MicroPulser Electroporation Cuvette (Bio-
Rad, Hercules, CA, USA). The cells were electroporated at 2.5 kV and 500 µL SOC 
(Super Optimal broth with Catabolite repression: SOB with 20 mM glucose) was 
added immediately. 
A liter of SOC medium was made as follows: 
20 g tryptone 
5 g yeast extract 
0.5 g sodium chloride 
This was made up to 950 mL, pHed to 7, made up to 1 L and autoclaved. Then, 5 
mL sterile 2 M MgCl2 and 20 mL sterile 1 M glucose were added. 
 
After electroporation, cells were recovered at 37 °C for one hour. Appropriate 
volumes of cells were spread on LB-agar plates with antibiotic as needed and 











Expression of His6-tagged 
SSO1638, PsSY77 GL7-






Expression of His6-tagged 
P. aeruginosa PAO1 HacB 
Atum  




Cloning of PsSY77 GL7-
ACA acylase 
Atum  
(Newark, CA, USA) 
 
The full-length PsSY77 GL7-ACA acylase gene sequence AF458663.1 (Uniprot 
P07662) was optimised for expression in E. coli and ordered from ATUM (Newark, 
CA, USA). The plasmid was extracted from filter paper by adding 100 µL 10 mM 
tris-HCl, pH 8.0, 0.1 mM EDTA, and collecting the supernatant by centrifugation. 
6.3.2 Primers	
Primers were designed using SnapGene (v. 3.2.1) and were ordered from 
Integrated DNA Technologies (Coralville, IA, USA). The lyophilised pellets were 
resuspended in 10 mM tris-HCl pH 8, 1 mM EDTA to a final concentration of 100 
µM and stored at -20 °C. Working stocks were made to a concentration of 10 µM 
in water and stored at 4 °C. 
Table 6.3 Primers used for cloning and sequencing. 
Name Sequence (5′ – 3′) Purpose 
T7.for TAATACGACTCACTATAGGG Sequencing plasmids with 
T7 promoter e.g. pET20b 
Overlap extension PCR 
T7.rev GCTAGTTATTGCTCAGCGG Sequencing plasmids with 
T7 terminator e.g. pET20b 
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Overlap extension PCR 
GK16-seq2 CGTTGGGCGAGGGTGACCCG Sequencing PsSY77 GL7-




Gibson assembly forward 
primer to amplify the 
PsSY77 GL7-ACA acylase 




Gibson assembly reverse 
primer to amplify the 
PsSY77 GL7-ACA acylase 
gene with a His6 tag 
GK16-vec2 F GGAACGTACTCCGTTCAACTTCAAG
CCGGGCCACCACCACCACCACCACT 
Gibson assembly reverse 
primer to amplify the 
pET20b with a His6 tag 
GK16-vec4 R GCTGGTTGGCTCCATATGTATATCTC
CTTCTTAAAGTTAAACAAAATTAT 
Gibson assembly forward 
primer to amplify the 
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Plasmids were digested using restriction endonucleases BamHI-HF 20000 U/mL, 
NdeI 20000 U/mL and SalI-HF 20000 U/mL from New England Biolabs 
(Ipswich, MA, USA) while PCR products were digested using BamHI-HF and 
NdeI. Both digests were carried out using CutSmartTM Buffer 10× from New 
England Biolabs (Ipswich, MA, USA). Restriction digests were carried out in a 
ratio of 1 µL enzyme to 1 µg DNA and incubated at 37 °C for four hours. 
Reactions were terminated by inactivation at 65 °C for ten minutes when 
necessary. 
6.3.4 Amplifying	DNA	
PCR was used to amplify DNA for cloning, construction of site-saturation 
mutagenesis libraries (Section 6.5.1) and screening colonies. For cloning, Phusion 
® HF DNA Polymerase 2000 U/mL, 5× Phusion ® HF Reaction Buffer, 10 mM 
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dNTPs and dimethyl sulfoxide (DMSO) from New England Biolabs (Ipswich, 
MA, USA) were used. Reactions were carried out as follows: 
PCR reaction  Thermal cycling  
5× Phusion HF or GC buffer 4 µL   
10 mM dNTPs 0.4 µL 98 °C 30 s  
10 µM forward primer 1 µL 98 °C 10 s  
10 µM reverse primer 1 µL 52 °C* 15 s  29 × 
Template DNA ~ 50 ng 72 °C 15 s†/1kb  
DMSO 0.6 µL 72 °C 5 min  
Phusion DNA polymerase 0.2 µL   
Nuclease-free water up to 20 µL   
total 20 µL   
*Annealing temperatures used were as predicted by SnapGene (v. 3.2.1) and 
optimised as necessary. 
 Colony screens were performed with KAPA Taq ReadyMix plus dye 2× and 10 
mM dNTP Mix from KAPA Biosystems (Wilmington, MA, USA). Reactions were 
carried out as follows: 
PCR reaction  Thermal cycling  
2× KAPA Taq ReadyMix 10 µL   
10 µM T7.for 0.8 µL 95 °C 4 min  
10 µM T7.rev 0.8 µL 95 °C 30 s  
Colony DNA 1 µL 55 °C 15 s  29 × 
Nuclease-free water up to 20 µL 72 °C 2.25 min  
total 20 µL 72 °C 5 min  
 
6.3.5 Ligating	DNA	
Ligations were performed on DNA with sticky ends to form full plasmids using T4 
DNA Ligase 20 U/µL, 10× Buffer with 10 mM ATP, from New England Biolabs 
(Ipswich, MA, USA). Reactions were carried out with a 3:1 ratio of insert to 
backbone, 20 U T4 DNA ligase and 1× reaction buffer. These were either 
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incubated at 16 °C or alternating cycles of 10 °C and 30 °C for ten seconds each, 
overnight. 
Gibson assembly was used to construct the pET20b PsSY77 -ss GL7-ACA acylase 
His6 expression plasmid. Reactions were carried out with a 3:1 ratio of insert to 
backbone and Gibson Assembly ® Master Mix 2× from New England Biolabs 
(Ipswich, MA, USA). These were incubated at 50 °C for three hours. 
6.3.6 Separating	and	quantifying	DNA	
DNA obtained from a restriction endonuclease digestion or PCR was separated via 
gel electrophoresis. A 1% w/v agarose gel was made with 1× TAE containing 500 
ng/mL ethidium bromide. DNA samples were mixed with DNA loading dye to 1× 
concentration where needed. A DNA ladder was loaded in parallel. DNA was 
separated in 1× TAE for twenty minutes at 110 V. Gels were visualised under UV 
light with a Universal Hood Gel Doc (Bio-Rad, Hercules, CA, USA).  
DNA required for cloning was separated in a gel containing 1× SYBR Safe dye. 
Gels were visualised with blue light (Safe Imager 2.0, Life Technologies, Eugene, 
OR, USA). The relevant bands were excised with a razor blade and the DNA was 
purified with the NucleoSpin ® Gel and PCR Clean-up kit from Macherey-Nagel 
(Düren, Germany).  
DNA was quantified by measuring absorbance at 260 nm in a BioPhotometer 
(Eppendorf, Hamburg, Germany). 
6.3.7 Sequencing	DNA	
For sequencing of PCR products, unused primers and nucleotides were removed 
beforehand using the ExoSAP-IT PCR Product Cleanup Reagent (Affymetrix, 
Santa Clara, CA, USA). Samples were 5 µL PCR product mixed with 2 µL reagent 
and incubated at 37 °C for fifteen minutes then 80 °C for fifteen minutes.  
PCR products or plasmids were sent to the University of Otago Genetic Analysis 





Expression was usually performed in TB-AIM with 0.4% w/v glycerol, 1:100 
dilution of the overnight culture and a final concentration of 0.1 mg/mL ampicillin 
or carbenicillin, or 0.03 mg/mL kanamycin. The cells were grown at 37 °C until 
the OD600 was ~0.7 then moved to 18 °C. This was done at 200 rpm shaking for 30 
hours to induce protein expression. Cells were harvested by centrifuging at 3000 g 
for fifteen minutes at 4 °C. Pellets were stored at -20 °C until purification. 
6.4.2 Protein	expression	optimisation	trials	
For SSO1638, over-expression was carried out in TB with 0.4% w/v glycerol and a 
final concentration of 0.1 mg/mL carbenicillin for twenty-four and forty hours. For 
the PsSY77 GL7-ACA acylase, over-expression was carried out in LB, TB with 
0.4% w/v glycerol and TB-AIM with 0.4% w/v glycerol and ampicillin for thirty 
hours at 18, 28 and 37 °C, respectively. Induction was performed using a final 
concentration of 1 mM IPTG. Aliquots prior and subsequent to induction were 
collected. Cells were harvested and stored until lysis. 
To determine if expression occurred, cells were lysed by resuspending in 3 mL lysis 
buffer (50 mM potassium phosphate, 300 mM sodium chloride, 10% w/v glycerol, 
pH 7.0) with 20 µL protease inhibitor cocktail, a final concentration of 0.5 mg/mL 
lysozyme and 100 U benzonase per gram cell pellet. This was sonicated and the 
total protein (crude lysate) was centrifuged at 30000 g for thirty minutes at 4 °C to 
give the soluble fraction (supernatant) and insoluble fraction (pellet). Samples were 
analysed by SDS-PAGE (Section 6.4.5). 
6.4.3 Immobilised	metal	ion	affinity	chromatography	gravity-flow	protein	
purification	
Cell pellets were resuspended in the lysis buffer with 0.5 mg/mL lysozyme, ~100 
U benzonase and protease inhibitor cocktail and vortexed for ten minutes. The 
resuspended pellet was then sonicated at 32% with 15 ten-second pulses (Vibra-Cell 
VCX500-750, Sonics & Materials, Inc., Newtown, CT, USA). Insoluble debris was 
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pelleted at 30000 g for forty minutes at 4 °C. The soluble fraction was clarified with 
a syringe-driven 0.45 µM filter. 
TALON resin was washed twice with ten bed volumes of lysis buffer. Bed volumes 
of ~100 µL per gram cell pellet was used. The clarified soluble fraction was added 
to the equilibrated resin and agitated at 4 °C for forty minutes to allow the His6-
tagged proteins to bind. The resin was centrifuged at 700 g for five minutes and the 
unbound fraction was discarded. The resin was washed twice with ten bed volumes 
of lysis buffer, agitated at 4 °C for ten minutes then centrifuged at 700 g for two 
minutes. Aliquots of all fractions were retained for analysis with SDS-PAGE 
(Section 6.4.5).  
The resuspended resin was transferred to a disposable plastic Poly-Prep 
Chromatography column (Bio-Rad, Hercules, CA, USA) and allowed to settle out 
of suspension. Buffer was allowed to flow through. The resin was washed once 
with five bed volumes of lysis buffer, then once with five bed volumes of two wash 
buffers, 50 mM potassium phosphate, 300 mM sodium chloride, 10% w/v glycerol, 
5 mM imidazole, pH 7.0 and 50 mM potassium phosphate, 300 mM sodium 
chloride, 10% w/v glycerol, 10 mM imidazole, pH 7.0 respectively. Five bed 
volumes of elution buffer (50 mM potassium phosphate, 300 mM sodium chloride, 
10% w/v glycerol, 150 mM imidazole, pH 7.0) were added to the resin and elution 
fractions were collected. Aliquots of all fractions were retained for analysis with 
SDS-PAGE (Section 6.4.5). Fractions of interest were concentrated in storage 
buffer and stored at -80 °C. 
6.4.4 Size	exclusion	chromatography	
The AKTA Prime (GE Healthcare Life Sciences, Piscataway, NJ, USA) lines 
(stored with 20% ethanol) were washed with degassed water then the Superdex 200 
10/300 GL column (GE Healthcare Life Sciences, Piscataway, NJ, USA) was 
loaded according to manufacturer’s instructions. The column and lines were 
equilibrated with 50 mM HEPES, pH 7.0, 50 mM sodium chloride, 10% w/v 
glycerol. Purified protein at ~ 400 µL was loaded into a 5 mL loop (GE Healthcare 
Life Sciences, Piscataway, NJ, USA). An automated purification protocol was 
used, at a pressure limit of 1.0 mPa and a flow rate of 0.4 mL/minute, where the 
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sample was injected for 2 mL, loaded on to the column for 4 mL then 1 mL 
fractions were collected. The column was calibrated with standard proteins 
thyroglobulin, bovine γ-globulin, chicken ovalbumin and equine myoglobin (Bio-
Rad, Hercules, CA, USA). Blue dextran and acetone were used to determine the 
void volume and total exclusion volume of the column, respectively. Fractions 
collected were analysed by SDS-PAGE (Section 6.4.5). Target protein-containing 
fractions were concentrated and used for crystallography. 
6.4.5 SDS-PAGE	
SDS-PAGE was used to visualize proteins. Four 0.75 mm gels can be prepared 
with the volumes below: 
 Resolving gel (12%) Stacking gel (5%) 
1.5 M Tris-HCl pH 8.8 5 mL - 
0.5 M Tris-HCl pH 6.8 - 2.5 mL 
Water 8.7 mL 3.2 mL 
SDS (10% w/v) 200 µL 50 µL 
Acrylamide/Bis (40% w/v) 6 mL 500 µL 
Ammonium persulfate (10% w/v) 200 µL 25 µL 
Tetramethylethylenediamine 20 µL 2 µL 
 
The gels were poured using a Mini-PROTEAN Tetra Cell casting frame and stand 
(Bio-Rad, Hercules, CA, USA).  
Protein samples were diluted 1:1 in 2× SDS-PAGE loading dye (100 mM Tris-Cl, 
pH 6.8, 4% w/v SDS, 20% v/v glycerol, 0.2% w/v bromophenol blue, 200 mM β-
mercaptoethanol) and denatured at 95 °C for five minutes. The gel was loaded with 
samples (8 µL per well in 15 well gels; 10-15 µL in 10 well gels) and 5 µL of a 
molecular weight standard. Once the SDS-PAGE gel was loaded, it was run in a 
Mini-PROTEAN tetra cell system (Bio-Rad, Hercules, CA, USA) at 200 V for 35-
45 minutes in SDS-PAGE running buffer (25 mM Tris pH 8.3, 250 mM glycine, 
0.1% w/v SDS). The gel was then stained with Coomassie stain (1.5 mM 
Coomassie R250, 50% v/v methanol, 10% v/v glacial acetic acid) for ~ 30 minutes 
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while rocking, and then transferred into destain solution (30% v/v methanol, 10% 
v/v acetic acid) until sufficiently destained. 
6.4.6 Mass	spectrometry	
Bands of interest from SDS-PAGE (Section 6.4.5) were sent to the Centre of 
Protein Research, University of Otago for identification. Bands were digested with 
trypsin and eluted for mass spectrometry. Analysis was carried out using MALDI 
tandem Time-of-Flight Analyzer or LC-MS-based protein profiling with nanospray 
LTQ-Orbitrap XL mass spectrometry coupled inline to an UltiMate 3000 nanoflow 
UHPLC. Proteins were identified based on comparisons of the pattern of the 
trypsin-digested peptides to those predicted from sequence databases. 
6.4.7 Concentration	and	quantification	of	purified	proteins	
Once proteins were purified, the relevant fractions were pooled and buffer 
exchanged in the appropriate storage buffer in Amicon Ultra centrifugal filter units 
(Merck, Darmstadt, Germany), according to the manufacturer’s instructions.  
Protein concentration was determined with a wavelength scan in a Cary UV-Vis 
spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) with an 80 µL 
quartz cuvette. A wavelength scan of buffer was carried out to determine the 
background absorbance then a wavelength scan of an appropriate protein dilution 
was carried out. The absorbance at 280 nm (A280) of the buffer-only reading was 
subtracted from the A280 of the protein reading. The protein concentration was 
calculated using the final absorbance reading, the equation of Beer’s law (A = ε.c.l) 
and each protein’s molecular weight and extinction coefficient calculated in 
Protparam (Gasteiger et al., 2005) respectively. 
6.4.8 Differential	scanning	fluorimetry	
Differential scanning fluorimetry was used to determine the stability of proteins in 
various buffers for storage and crystallography (Pantoliano et al., 2001). Each assay 
was carried out as follows: 
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 Volume [Final] 
SYPRO Orange 6 µL 5× 
Protein Various 5 µM 
Buffer 10 µL 1× 
H2O - To 20 µL 
 
Plates were sealed with Lightcycler 480 sealing foil and samples were heated from 
20 to 80 °C at a ramp rate of 1.2 °C min−1 in a Roche Light-Cycler 480 Real-Time 
PCR instrument. The protein unfolding curves were monitored by detecting 
changes in SYPRO Orange fluorescence. The first derivative values (−dF/dt) from 
the raw fluorescence data were used to determine the temperature at which the 




This was done using a protocol modified from Sio et al. (2002). The reaction was 
carried out in 20 mM potassium phosphate pH 7.0 at 37 °C. Vmax and KM were 
determined using GL7-ACA concentrations of 2, 1, 0.5, 0.25, 0.1, 0.05 and 0.025 
mM. The reaction was carried in a 500 µL reaction for 5 minutes with 1.5 µg (39 
nM) purified protein. An aliquot of 200 µL of the reaction mixture was added to 
520 µL 0.5 M potassium acetate pH 4.5 and 80 µL 1 mg/mL fluorescamine in 
acetone was added. This was incubated at room temperature for one hour. 700 µL 
of this mixture was placed in a quartz cuvette and absorbance at 378 nm was 
measured. The absorbance values were calibrated using a 7-ACA standard curve. 
6.4.9.2 AHL	acylase	assays	
For quantifying specific enzyme activity, assays were carried out in 100 mM 
potassium phosphate pH 7.0 at 30 °C with 100 µM AHL and 100 nM purified 
protein. This was incubated in 1 mL for periods optimised so that signals were 
distinguishable from background and so that enzyme activity remains linear. 
Aliquots of 200 µL of the reaction mixture were transferred to 96-well flat bottom 
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black microplates and 25 µL of 3 mg/mL fluorescamine was added. The gain on 
the Clariostar was set using a 100 µM HSL standard in the plate. The relative 
fluorescence values were calibrated using a HSL standard curve. 
To calculate specific enzyme activity, background fluorescence is subtracted from 
samples. This value is converted to amounts of product in µmol using the equation 
of the HSL standard curve. These values are then divided by the assay period in 
minutes and the amount of protein in mg to calculate the specific enzyme activity 
(µmol min-1 mg-1). 
6.4.10 Crystallisation	trials	
For initial crystallisation trials of the Arg255Gly variant, commercial screens were 
used. This consisted of the JCSG-plus screen, PACT Premier (Molecular 
Dimensions, UK) and in-house screens from the University of Auckland: a 
PEG/Ion screen, Hampton Crystal Screens I and II (Hampton Research, Aliso 
Viejo, CA, USA), a systematic PEG-pH screen (Kingston et al., 1994), the 
Footprint Screen No. 1 and PEG Footprint Screen (Stura et al., 1992). The 
Arg255Gly variant was purified by size exclusion chromatography (Section 6.4.4). 
The screens were carried out with 4 as well as 30 mg/mL of the Arg255Gly 
variant. The trials were set up using the hanging drop vapour diffusion technique in 
Corning ® Costar ® 96-well flat bottom clear microplates (Sigma Aldrich, St. 
Louis, MO, USA) with viewdrop II 96-well plate seals (TTP LabTech, UK). Each 
well contained 200 µL well solution and each drop consisted of 1:1 ratios of well 
solution to protein at a volume of 200 nL. The automated Mosquito robot system 
was used to spot solutions on the plate seal. The plate seal was inverted and sealed 
on to the corresponding 96-well plate. Plates were incubated at 16 °C. Drops were 
imaged by Rock Imager (Formulatrix, Bedford, MA, USA) every three days. 
Based on a potential hit in the screens from the University of Auckland (Robot 
screen 1, A10) and the literature (Kim et al., 2006; Cho et al., 2009), an optimised 
trial was carried out against the Arg255Gly variant. This was done using 100 mM 
sodium cacodylate, 200 mM magnesium chloride and varying pH (pH 6, 6.5 and 
7), molecular weights and concentrations of polyethylene glycol (PEG 3350, 5000, 
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6000 and 800 at 16 and 20%) and protein concentrations (15, 20, 25, 30 mg/mL). 
The same techniques were used as for the trials with commercial screens. 
6.4.11 Computational	modelling	
To understand the C10-, C12- and 3-oxo-C12-HSL acylase activity of the 
Arg255Gly variant, docking simulations were carried out using the Genetic 
Optimisation for Ligand Docking (GOLD) program (Jones et al., 1997). Water 
molecules were first removed from the PsSY77 GL7-ACA acylase structure (PDB 
1OR0) and the Arg255 residue was mutated to glycine using PyMol (Version 1.8, 
Schrödinger, LLC). The oxygen atom on the side-chain of Ser199 was used as the 
centre of the binding site with a radius of 10 Å. Structures of C10-, C12- and 3-oxo-
C12-HSL (PubChem CID 10131281, 10221437 and 127864, respectively) were 
obtained from the PubChem Compound Database (Kim et al., 2015) for docking. 
Each ligand was docked into the Arg255Gly model ten times at the automatic 
docking speed, where GOLD calculates the optimal number of times for the 
operation of its genetic algorithm. For each ligand docked, solutions were scored 







The site-saturation mutagenesis libraries were constructed using over-lap extension 
PCR (Williams et al., 2014) (Section 6.3.4). Two fragments of the PsSY77 GL7-
ACA acylase gene were amplified using the T7.for primer with corresponding 
reverse mutagenic primers and the T7.rev primer with corresponding forward 
mutagenic primers (Table 6.3). For libraries made using the 22c-trick (Kille et al., 
2012) (Figure 6.1), the 10 µM mutagenic primers were mixed according to the ratio 
of 12:9:1 for NDT:VHG:TTG (Table 6.3). 
 
Figure 6.1 22c site saturation mutagenesis. Codons and represented amino 
acids are shown. Adapted from Kille et al. (2012). 
 
After this amplification, methylated template DNA was digested by incubation at 
37 °C for two hours with 0.5 µL DpnI (20 U/µL) (New England Biolabs, Ipswich, 
MA, USA). The PCR products were separated as described in Section 6.3.6. The 
correct-sized bands were excised and purified using the NucleoSpin Gel and PCR 
Clean-up kit (Macherey-Nagel, Düren, Germany). 
Overlap extension was carried out to assemble the two gene fragments into a single 
insert using T7 primers (Table 6.3) and ~50 ng of each gene fragment as template 
DNA. The products were purified as described in Section 6.3.6. 
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The overlap extension PCR products and the pET20b PsSY77 -ss GL7-ACA 
acylase His6 plasmid were digested with restriction endonucleases (Section 6.3.3). 
Digested DNA was purified (Section 6.3.6) and the digested PCR products were 
then ligated to the digested plasmid (Section 6.3.5). Resulting plasmids were used 
to transform electrocompetent E. coli BL21(DE3) cells (Section 6.2.4). 
Colony screens were carried out for each library (Section 6.3.4) to determine the 
number of wild-type or ambiguous sequences present. Ten randomly selected 
colonies were picked into 5 µL water and used to provide template DNA. PCR 
products were sent for sequencing (Section 6.3.7).  
The diversity of the 22c libraries was assessed using the Quick Quality Control 
method (Acevedo-Rocha et al., 2015). Library colonies were scratched from LB 
agar plates with a spatula and 2 mL sterile water. The cells were resuspended in 
water and plasmids were purified using the E.N.Z.A. Plasmid Mini Kit I 
(OMEGA Bio-Tek, Norcross, GA, USA). Plasmids were sent for sequencing 
(Section 6.3.7) and sequence files were interpreted using MacVector (v. 12.7.5).  
Colonies were picked into 96-well plates containing 150 µL LB with antibiotics to 
grow overnight at 37 °C 100 rpm shaking in an IncuMix plate shaker. For each 
residue mutated, a single 96-well plate library was made, containing 5 controls and 
91 potential variants. Freezer stocks were made as described in Section 6.2.2. 
6.5.2 Library	expression,	purification	and	screens	
Protein over-expression of the libraries was carried out as described in Section 
6.4.1 with 1 mL TB-AIM with 0.4% w/v glycerol per well in 2.2 mL 96-well deep 
well plates (Labcon, Petaluma, CA, USA). Libraries were grown at 37 °C for three 
hours then moved to 18 °C for thirty hours to induce protein expression using an 
IncuMix plate shaker. This was carried out with 600 rpm shaking. Cells were 
harvested by centrifuging at 3000 g for fifteen minutes at 4 °C. Pellets were stored 
at -20 °C until purification.  
Libraries were purified using HisPur Cobalt Spin Plates (Thermo Fisher Scientific, 
Waltham, MA, USA). Buffers used were the same as described in Section 6.4.3. 
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The spin plate was washed with water and lysis buffer before purification. Cell 
pellets were lysed by shaking at 900 rpm for forty minutes with 200 µL lysis buffer 
including 0.5 mg/mL lysozyme, 2.5 U benzonase nuclease and 1 µL protease 
inhibitor cocktail per well. The libraries were centrifuged at 3000 g at 4 °C for 
fifteen minutes to pellet the insoluble fraction. The soluble fractions were applied to 
the spin plate then centrifuged to remove the unbound fraction. The spin plate was 
washed with the two wash buffers respectively at 240 µL per well. Proteins were 
eluted with elution buffer at 300 µL per well. The spin plate was cleaned with 6 M 
guanidium hydrochloride, 1% Triton X-100 after each purification. The spin plate 
was stripped with 500 mM EDTA pH 7 and recharged with 100 mM cobalt (II) 
chloride after triplicate purification of each library. 
Working stocks of GL7-ACA and AHLs were prepared in 100 mM potassium 
phosphate pH 7.0 to a concentration of 210 µM. Each well of a screen in 96-well 
flat bottom black microplates was as follows:  
 Volume per well [Final] 
Elution fraction 10 µL  
210 µM AHL or GL7-ACA 190 µL 200 µM 
 200 µL  
 
Assay plates were incubated at 30 °C 100 rpm shaking for twenty-four hours. After 
this, 25 µL fluorescamine dissolved in acetone at 3 mg/mL was added to each well. 
Relative fluorescence units were measured on the CLARIOstar Microplate Reader 
(BMG LabTech, Cary, NC, USA). The gain on the Clariostar was set using a 200 
µM product (HSL or 7-ACA) standard in the respective plates. Data was analysed 






A liter of 5× M63 was made as follows: 
15 g potassium dihydrogen phosphate 
35 g dipotassium hydrogen phosphate 
10 g ammonium sulfate 
This was made up to to 1 L and autoclaved. 
 
Fifty mL 1× M63 for biofilm growth in Calgary Biofilm Device 96-well plates 
was made as follows: 
49 mL 1× M63 (prepared from 5× M63 diluted 1:4 with sterile water) 
50 µL sterile 1 M magnesium sulfate 
12.5 µL sterile iron (III) chloride 
1 mL sterile 20% w/v arginine  
 
A liter of phosphate-buffered saline (PBS) was made as follows: 
0.2 g potassium chloride 
1.44 g disodium hydrogen phosphate 
0.24 g potassium dihydrogen phosphate 
This was made up to 950 mL, pHed to 7.4, made up to 1 L and autoclaved. 
 
6.6.2 Biofilm	growth	
P. aeruginosa strains (Table 6.1) were grown as described in Section 6.2.2. 
Overnight cultures were diluted to an OD600 of 0.015 in 1× M63 media (Section 
6.6.1). From these diluted samples, 180 µL was pipetted into wells of the Calgary 
Biofilm Device (Innovotech, Canada). Filter-sterilised enzyme was then added to 
each well to a final concentration of 100 nM, and the same volume of sterile buffer 
as control. The lid containing pegs was placed on top of the plate and sealed. 
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Biofilms were grown for 24 hours at 37 °C with 300 rpm shaking. The media was 
then changed, fresh enzyme was added and biofilms were grown for a further 24 
hours. 
6.6.3 Quantifying	total	biofilm	mass	
Peg plate lids were transferred to plates containing 180 µL sterile PBS (Section 
6.6.1) for five minutes, then transferred to plates containing 180 µL 0.1% w/v 
crystal violet and stained for 20 minutes. Peg plate lids were submerged in distilled 
water three times to rinse off excess stain and air-dried overnight. Peg plate lids 
were transferred to plates containing 180 µL 33% acetic acid and sonicated for 15 
minutes to solubilise the stained biomass. Aliquots of 125 µL were transferred to 
96-well flat bottom transparent microplates and absorbance at 590 nm was 
measured. 
6.6.4 Scanning	electron	microscopy	
Pegs were removed from the Calgary Biofilm Device and biofilms grown on the 
pegs (Section 6.6.2) were fixed with 2.5% gluteraldehyde (Electron Microscopy 
Sciences, Hatfield, PA, USA) for one hour, and then washed three times with PBS 
(Section 6.6.1). Biofilms were exposed to 1% osmium tetraoxide (Electron 
Microscopy Sciences, Hatfield, PA, USA) for one hour, and then washed three 
times with PBS for additional fixation and staining. Biofilms were then dehydrated 
with washes in 30, 50, 70, 85 and 95% ethanol solutions for 10 minutes each then 
three washes in absolute ethanol for 20 minutes each. Biofilms were dried using a 
Bal-Tec CPD-030 critical point drier (Bal-TecAG, Balzers, Liechtenstein) by 
gradual exchange of ethanol with liquid carbon dioxide (BOC Gas, New Zealand), 
then sputter coated with ~15 nm thick layer of a gold palladium alloy or platinum 
(Testbourne Ltd, UK) to ensure minimal charging of samples. Images were taken 
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Appendix Figure 1 Activity of PsSY77 GL7-ACA acylase against AHLs and GL7-
ACA. RFU represents relative fluorescence units. 
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Appendix Table 1 Structures of PvdQ. 
PDB ID Ligands/mutations Reference 
2WYB Dodecanoic acid covalently bound 
 
Bokhove et al. (2010) 
2WYC*# 3-oxo-dodecanoic acid 
2WYD# Dodecanoic acid 
2WYE No ligand 
3L91# Octanoic acid 
Drake and Gulick (2011) 
3L94 Tetradecanoic acid covalently bound 
3SRA 








4M1J Inhibitor tridecylboronic acid Clevenger et al. (2013) 








4WKS Inhibitor 1-ethylboronic acid 
Clevenger et al. (2014) 
4WKT Inhibitor 1-butylboronic acid 
4WKU Inhibitor 1-hexylboronic acid 
4WKV Inhibitor 1-octylboronic acid 
5UBK 
Circularly-permuted Ser217Ala/Asn485Asp 
variant with pyoverdine precursor PVDIq Clevenger et al. (2017) 
5UBL Circularly-permuted variant 








P. aeruginosa PAO1 
PvdQ AHL acylase* 
distance (Å) 
Met174 1.6 Leu170 4.8 
Tyr178 4.8 Glu172 9.1 
Leu222 4.8 Phe240 3.9 
Gln248 3.9 Leu266 3.9 
Arg255 clash Asn273 4.7 
Met347 2.0 Val374 3.5 
Phe375 3.4 Val403 4.4 
*Residues labelled according to full-length sequence. 
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Liu et al. (2017) 
MacQ Acidovorax sp. MR-
S7 
A0A0A1VBK6 Kusada et al. (2017) 
QqaR Deinococcus 
radiodurans 
Q9RYQ4 Koch et al. (2014a) 
PaHacB Pseudomonas 
aeruginosa PAO1 
Q9I6I6 Wahjudi et al. (2011) 
PsyrHacA Pseudomonas 
syringae B728 




Q4ZLT7 Shepherd and Lindow 
(2009) 
AiiC Anabaena sp. 
PCC7120 
Q8YQA9 Romero et al. (2008) 
Aac Shewanella sp. 
MIB015 
A9CPH6 Morohoshi et al. (2008) 
PaQuiP Pseudomonas 
aeruginosa PAO1 
Q9I4U2 Huang et al. (2006) 
PaPvdQ Pseudomonas 
aeruginosa PAO1 
Q9I194 Sio et al. (2006) 
AhlM Streptomyces sp. 
M664 
Q50H45 Park et al. (2005) 




Appendix Table 4 Comparison of PsSY77 GL7-ACA and AHL acylase residues. 
*, catalytic residues. −, no aligned sequence. Residues in bold match those in 
























Met174 Asn Asn Val Arg Ala Arg Leu Leu Ala Leu Ile Leu 
Tyr178 Arg Ala Thr Arg Ala Lys Glu Phe Ala Glu Thr Val 
Ser199* conserved 
His221* conserved 
Leu222* Leu Trp Phe Ile Phe Ile Leu Phe Leu Phe Tyr Phe 
Gln248 Leu Phe Leu Gln Leu Pro − Leu Ile Leu Leu Ile 
Arg255 Ile Gln Asn Ser Asn Leu Ile Asn Val Asn Ser Ser 
Val268* Asn Val Val Met Val Met Asn Phe Met Val Val Val 
Met347 Ser Thr Met Val Val Val Leu Pro Thr Val Met Ser 






Appendix Figure 2 Variability of controls from all library screens. (A) C12- and 3-





Appendix Figure 3 Range of background signal from DMSO-only screens for 










Appendix Figure 4 AHL acylase activity of the Arg255Gly variant over time. (A) 











Appendix Figure 5 AHL acylase activity of the Arg255Ala variant over time. (A) 




Appendix Figure 6 Modelling of AHLs into the PsSY77 GL7-ACA acylase 
Arg255Gly. C10-HSL in blue sticks, C12-HSL in cyan sticks, PsSY77 GL7-ACA 








Appendix Figure 7 Scanning electron microscopy images of P. aeruginosa 
biofilms from the laboratory strain. (A) Untreated. (B) Treated with GL7-ACA 









Appendix Figure 8 Scanning electron microscopy images of P. aeruginosa 
biofilms from a clinical isolate. (A) Untreated. (B) Treated with GL7-ACA acylase. 
(C) Treated with GL7-ACA acylase Arg255Gly variant. Images taken at 4000x 
magnification. 
 
 
